Effect of Ternary Additives on the Evolution of Structure Formation in Aqueous PEO-PPO-PEO Micelles by Thompson, Andre
 
 
Effect of Ternary Additives on the Evolution of Structure 
Formation in Aqueous PEO-PPO-PEO Micelles 
 
by 
 
Andre Lamont Thompson 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of  
Doctor of Philosophy 
(Materials Science and Engineering) 
in the University of Michigan 
2018 
 
 
 
Doctoral Committee: 
 
 Professor Brian J. Love, Chair 
Assistant Professor Geeta Mehta  
 Professor Michael J. Solomon 
Associate Professor Anish Tuteja 
  
  
Andre Lamont Thompson 
andrelt@umich.edu 
ORCID iD: 0000-0001-5717-6902 
 
© Andre Lamont Thompson 2018 
ii 
 
ACKNOWLEDGMENTS 
 
 I sincerely thank my advisor, Brian Love, for his friendship and mentorship throughout 
my graduate schooling. His guidance and support have been essential in my academic 
development and success. I also like to thank my advisors at DuPont, Portia Yarborough, and at 
NIST, Rick Davis, for their advice and mentorship throughout this challenging process.  
I acknowledge the Rackham Graduate School at UM for support. I also like to thank the 
GEM Fellowship funded through DuPont and the National Physical Science Consortium (NPSC) 
Fellowship funded through the National Institute of Standards and Technology (NIST) for their 
financial support. I also thank the numerous teachers, colleagues, and lab mates with whom I 
have had the pleasure of interacting with and learning from throughout the research projects 
outlined in this dissertation.  
Lastly, I thank friends, family, loved ones, my friends in SMES-G and AGEP, and my 
community at Oak Grove A.M.E. Church for being in my corner and cheering me on and 
providing motivation and words of encouragement along this academic journey. As well as all of 
my teammates on my UM intramural teams, that provided me with fun times and great memories 
along this journey. I am grateful to have so many people in my life that have helped develop me 
into the research scientist, engineer, and person I am today.    
 
 
 
  
iii 
 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGMENTS ................................................................................................ ii 
LIST OF FIGURES ...........................................................................................................v 
LIST OF TABLES ......................................................................................................... viii 
ABSTRACT ...................................................................................................................... ix 
CHAPTER 
I. Background and Motivation .........................................................................................1 
1.1 Amphiphilic Triblock Copolymers ....................................................................1 
1.2 Micellization Process .........................................................................................1 
1.3 Applications of Micelle Gels .............................................................................3 
1.4 Micelle Gels for Chemotherapeutic Applications..............................................4 
1.5 Previous Research of Micelle Gels for Drug Delivery ......................................5 
1.6 Motivation ..........................................................................................................6 
II. Thermodynamic Characterization of Micelle Formation .........................................8 
2.1 Introduction ........................................................................................................8 
2.2 Materials and Methods .....................................................................................14 
2.3 Results and Discussion ....................................................................................15 
2.3.1 DSC Results for Neat Micelles in Aqueous Solution .......................15 
2.3.2 Critical Micelle Concentrations ........................................................16 
2.3.3 Effect of Methylparaben on Micelle Formation Energetics .............21 
2.3.4 Effect of Cisplatin on Micelle Formation Energetics .......................24 
2.4 Conclusions ......................................................................................................29 
2.5 Acknowledgments............................................................................................30 
III. Structural Analysis of Micelle Formation ...............................................................31 
3.1 Introduction ......................................................................................................31 
3.2 Materials and Methods .....................................................................................33 
3.2.1 Solution Preparation..........................................................................33 
3.2.2 Small-Angle X-Ray Scattering (SAXS) ...........................................34 
3.2.3 Data Collection and Analysis............................................................34 
3.3 Results and Discussion ....................................................................................36 
3.3.1 Phase Structure Identification ...........................................................36 
3.3.2 Unit Cell Size ....................................................................................43 
3.3.3 D-spacing and Thermal Expansion ...................................................47 
3.4 Conclusions ......................................................................................................51 
iv 
 
3.5 Acknowledgments............................................................................................53 
IV. Diffusion and Controlled Release of Colloidal Gels ...............................................54 
4.1 Introduction ......................................................................................................54 
4.2 Materials and Methods .....................................................................................55 
4.2.1 Ternary Additives .............................................................................55 
4.2.2 Kinetics of Ternary Additives Release from Pluronic F127 .............56 
4.3 Results and Discussion ....................................................................................58 
4.3.1 Calibration Curves of Ternary Additives ..........................................59 
4.3.2 Kinetics of Malachite Green .............................................................62 
4.3.3 Kinetics of Erythrosin Release..........................................................64 
4.3.4 Kinetics of Cisplatin Release ............................................................67 
4.3.5 Comparison of Other Permeation Experiments ................................70 
4.4 Conclusions ......................................................................................................73 
4.5 Acknowledgments............................................................................................74 
V. Micelle Gels as Fire Retardants .................................................................................75 
5.1 Introduction ......................................................................................................75 
5.2 Materials and Methods .....................................................................................78 
5.2.1 Materials ...........................................................................................78 
5.2.2 Coating Procedure .............................................................................79 
5.2.3 Flammability Testing ........................................................................80 
5.3 Results and Discussion ....................................................................................81 
5.3.1 Fabrication and Flammability Screening ..........................................81 
5.3.2 Instrumentation: TGA, MCC, and SEM ...........................................84 
5.3.3 Comparison to Other Technologies ..................................................89 
5.4 Conclusions ......................................................................................................91 
5.5 Acknowledgments............................................................................................92 
VI. Summary and Future Work .....................................................................................93 
6.1 Summary ..........................................................................................................93 
6.2 Future work ......................................................................................................97 
References .......................................................................................................................101 
  
v 
 
 
LIST OF FIGURES 
 
Figure  
 
1.1 Temperature-dependent micellization and gelation of Pluronic surfactants ............2 
2.1  (a) Examples of Pluronics F108, P105, P104, and L101 (b) example of  
PEO-PPO-PEO micelle structure (c) methylparaben (d) cisplatin ........................15 
2.2       Increasing the concentrations of P105 in water also increased the enthalpy .........16 
2.3 DSC results at P105 content: the critical micelle concentration (cmc) of neat  
 Pluronic P105 was noted between 0.2% and 0.4% mass v-1 ..................................17  
2.4 DSC results at low P104 content: the critical micelle concentration (cmc) of  
 neat Pluronic P104 was noted at ~0.5% mass v-1 at 24.5oC by DSC .....................18 
2.5 DSC results at low L101 content: the critical micelle concentration (cmc) of 
neat Pluronic L101 was noted at ~3.0% mass v-1 at ~12.5 oC by DSC .................19 
2.6 DSC results at low F108 content: the critical micelle concentration (cmc) of 
 neat Pluronic F108 was noted ~4.0% mass v-1 at ~29.4oC by DSC ......................20 
2.7 Increasing concentrations of methylparaben in 10% P105 reduces both Tmicelle  
and H ...................................................................................................................22 
2.8 The enthalpy-entropy (H-S) compensation plot for P105, solutions both neat 
  (grey squares) and co-formulated with MP (blue circles) [72]. Upper and lower  
bounds for neat P105 (yellow line slope = 297 K, and red line slope = 281 K 
respectively) and co-formulated with MP (blue line slope = 340 K, and green  
line slope = 317 K) represent 95% confidence intervals .......................................23  
2.9 The enthalpy-entropy (H-S) compensation plot for P105, both neat (red  
 squares) and co-formulated with cisplatin (green triangles). Upper and lower  
 bounds for neat P105 (grey line slope = 297 K, and yellow line slope = 281 K 
respectively) and co-formulated with cisplatin (blue line slope = 290 K, and  
 green line slope = 288 K) represent 95% confidence intervals .............................25 
2.10 The enthalpy-entropy (H-S) compensation plot for P104, both neat (blue  
squares) and co-formulated with cisplatin (orange circles). Upper and lower  
bounds for neat P104 (grey line slope = 308 K, and yellow line slope = 296 K 
respectively) and co-formulated with cisplatin upper and lower bounds (blue  
line slope = 291 K, and green line slope = 287 K respectively) represent 95%  
confidence intervals ...............................................................................................26 
2.11 Schematic showing how cisplatin is distributed within micelles partitioning  
 between the PEO corona and the core-shell interface with PEO-PPO-PEO 
 Pluronic P104 .........................................................................................................28 
3.1 Comparison of peak identifications of neat P104 (31% mass v-1) and P104  
mixed cisplatin (0.1% mass v-1) at 28oC ................................................................37 
vi 
 
3.2 Comparison of peak identifications of neat P105 (31% mass v-1) and P105  
mixed cisplatin (0.1% mass v-1) at 28oC ................................................................39 
3.3 Comparison of peak identifications of neat F108 (31% mass v-1) and F108  
mixed cisplatin (0.1% mass v-1) at 28oC ................................................................40 
3.4 Neat P104 (31% mass v-1) and cisplatin (0.02-0.1% mass v-1) mixed P104 unit  
cell determination (q/2π)2 versus (h2 + k2 + l2) from Equation (3.1) .....................44 
3.5 Neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed P105 unit cell 
determination (q/2π)2 versus (h2 + k2 + l2) from Equation (3.1) ............................45 
3.6 Neat F108 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed F108 unit  
cell determination (q/2π)2 versus (h2 + k2 + l2) from Equation (3.1) .....................46 
3.7 d-spacing (Å) of neat P104 (31% mass v-1) and cisplatin (0.02%-0.1% mass v-1)  
mixed P104 with increasing temperature ...............................................................47 
3.8 d-spacing (Å) of neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1)  
mixed P105 with increasing temperature ...............................................................49 
3.9 d-spacing (Å) of neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1)  
mixed P105 with increasing temperature ...............................................................50 
4.1 (a) Pluronic F127 (b) example of PEO-PPO-PEO micelle structure (c) malachite 
 Green chloride (d) Erythrosin B dye (e) cis-dichlorodiammineplatinum(II) 
 Cisplatin .................................................................................................................56 
4.2 Setup of dialysis tubing experiment (a) at start of dialysis (b) at equilibrium .......57 
4.3 Neat malachite green absorption vs concentration calibration curve. Absorption 
 Analysis were measured in 500ml deionized water using UV-vis at wavelengths 
 610-620nm .............................................................................................................59 
4.4 Release of neat malachite green, MG, and malachite green-F127, MG-F127, at  
 Room temperature, RT, and 40oC over time. Each condition the malachite green 
 Release was measured in 500ml deionized water by UV-vis at wavelengths 610- 
 620nm ....................................................................................................................62 
4.5 Release of neat erythrosin, ER, and erythrosine-F127, ER-F127, at room temp, 
 RT, and 40oC over time. Each condition of the erythrosin release was measured 
 In 500ml deionized water by UV-vis at wavelengths 520-530nm ........................65 
4.6 Release of neat cisplatin and cisplatin-F127 at room temperature, RT, and 
 40oC over time. Each condition of the cisplatin released was measured in 500ml 
 Deionized water by UV-vis at wavelengths 250-270nm .......................................68 
5.1 (a) F127 (b)sodium hexametaphosphate (c) melamine ..........................................79 
5.2 Example of vertical flame test (VFT) setup ...........................................................81 
5.3 TGA data for F127/melamine/SHMP gel coating on cotton fabric (blue dots), 
melamine/SHMP (red solid line), uncoated cotton fabric (black dash-dots),  
and coating paste itself without cotton fabric (green dashes) ................................84 
5.4 MCC results of F127/melamine/SHMP gel coating on cotton fabric (blue dots), 
melamine/SHMP (red solid line), uncoated cotton fabric (black dash-dots),  
and coating paste itself without cotton fabric (green dashes) ................................86 
5.5 SEM images (a) cotton control (b) 15% F127/15% melamine/15% SHMP on  
cotton fabric (c) 5% melamine/5% SHMP on cotton fabric. The 5% melamine/ 
5% SHMP coating is not very uniform on the cotton fibers and is randomly  
dispersed. The 15% F127/15% melamine/15% SHMP coating shows a more  
uniform coating on the cotton fibers but there are noticeable cracks which  
vii 
 
indicates insufficient adhesion of the paste onto the cotton fabric ........................88 
5.6 Comparison of MCC data for F127, melamine, and SHMP coatings to the  
previously reported single bath, LbL, and MDPA/TMM coatings on or  
deposits within cotton fabrics. Mass gain % (blue), residue % (orange),  
THR (kJ/g) % reduction (grey), and PHRR (W/g) % reduction (yellow) for  
each recipe is compared.  Data is reported with a 2σ uncertainty .........................90 
6.1 The variation of neutron scattering lengths as a function of atomic number.........98 
  
viii 
 
 
LIST OF TABLES 
 
Table 
 
2.1 DSC results for P105 in H2O .................................................................................16 
2.2 Copolymer cmc values, compensation values, and correlation values of neat 
 and co-formulated with cisplatin. Each compensation temperature was tested to 
determine whether the slopes were statistically significantly different from one  
 another with a 95% confidence interval.................................................................27 
3.1 Summary of expected peaks and relative peak positions for the bcc and fcc 
 crystal systems .......................................................................................................35 
3.2 Fundamental (q0) and higher order (qn) peaks (in units of Å
-1), identified  
phase structure, fcc (a), bcc (b), unit cell size, 𝑎 (Å), and linear thermal  
expansion coefficient, αL (oC-1), at 28oC for neat P104, P105, and F108  
(31% mass v-1) and mixed cisplatin (0.02% - 0.1% mass v-1) ...............................42 
4.1 Wavelength ranges, concentration ranges, slopes, y-intercepts, and correlation 
 Values of malachite green, erythrosin, neat cisplatin, dark colored cisplatin, 
 and cisplatin complex ............................................................................................60 
4.2 Diffusion coefficient of each experimental condition: neat malachite green, 
 MG, erythrosin, ER, and cisplatin (first 5 hours) and mixed F127 at room 
 temperature, RT, and 40oC. Our results are compared to the in vitro release 
 of cisplatin from core-shell poly(lactide-co-glycolide) (PLGA) nanoparticles, 
 PLGA microspheres, solid fibers, and hollow fibers, and electrostatically cross- 
 linked chitosan-alginate nanoparticles ...................................................................71 
5.1 Coating composition, mass gain %, and open flame screening for flame  
retardant-coated cotton fabrics.  Mass gain is reported with a 2σ uncertainty ......82 
5.2 TGA properties of uncoated cotton fabric, melamine/SHMP on cotton, 
F127/melamine/SHMP gel coating on cotton, and F127/melamine/SHMP  
coating paste itself. Data is reported with a 2σ uncertainty.  The slopes correspond  
to the dehydration of the coated fabric (1) followed by the active combustion of  
the dehydrated composite (2) .................................................................................84 
5.3 Heat release properties of uncoated cotton fabric, melamine/SHMP on cotton, 
F127/melamine/SHMP gel coating on cotton, and F127/melamine/SHMP  
coating paste itself. Data is reported with a 2σ uncertainty ...................................87 
 
 
 
  
ix 
 
 
ABSTRACT 
 
 
Amphiphilic solutions and dispersions represent a key way that low solubility additives 
can be mixed within aqueous systems. While the phase behavior and gel structure of neat micelle 
solutions have been well studied, less is known about the effects of ternary constituents like a 
low solubility additive on micelle structure. In this dissertation, we probe the link between 
amphiphile micelle gels housing other hydrophilic or hydrophobic molecules and the effect on 
permeability and flame retardancy.   
Differential scanning calorimetry was performed on solutions of poly(ethylene oxide)-
poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) (L101, 10% PEO; P104, 40% 
PEO; P105, 50% PEO; and F108, 80% PEO) amphiphiles (0-2% mass/v) to resolve their critical 
micelle concentrations (0.4-3.0% mass/v). Work was done from 2-10% mass/v copolymer 
concentrations and co-formulated methylparaben and cisplatin (0-0.1% mass/v) to resolve any 
deviation in the enthalpy of micelle formation (250-360 kJ/mol). Enthalpy-entropy compensation 
plots revealed combinations of both drug influenced and drug invariant interaction with forming 
micelle structures. P104 was most sensitive with cisplatin over all other amphiphiles, noted as a 
decrease from 302K to 289K when containing up to 0.1% cisplatin. The statistical significance of 
this cisplatin-induced perturbation was a linear regression from the H-S plots and it was 
significant at a 95% confidence interval. Other cisplatin-amphiphile combinations were more 
statistically insignificant.   
x 
 
Small-angle x-ray scattering determined temperature dependent colloidal crystal 
formation in 31% amphiphile solutions both neat and co-formulated with cisplatin (up to 0.1% 
mass/v).  Focusing on P104, we noted a ~4.0% rise in crystal expansion over the 25oC 
temperature sweep.  Adding cisplatin results in a 4-5% reduction in the unit cell dimensions, 
which is attributed to decreased water content in the hydrophilic corona by adding cisplatin. 
Upon heating, added drug changed the nucleation behavior within the sample from a 
homogenous process to a more heterogeneous distribution of nucleated species.  
Dynamic diffusion experiments were performed on 20% mass/v micelle gels (F127, 70% 
PEO) mixed with indicator dyes and cisplatin (0.1% mass/v) by UV-visible spectroscopy. Each 
additive was tested neat at room temperature and 40oC, and formulated with F127 at room 
temperature and 40oC. The behavior of the added drug was complicated as the first 5 hours of 
permeation resulted in a burst delivery (6% total release with cisplatin-F127-RT compared to 4% 
cisplatin-RT). The higher fluence at elevated temperature is attributed to coalescing the 
amphiphiles that blocked transport on the tube walls as they formed colloidal gels. There is likely 
a separate factor at higher temperature and higher permeability if the membrane pores also 
expand with temperature.  
Lastly, micelle gels (F127) were used for fire retardants for cotton. Vertical flame tests, 
thermogravimetric analysis (TGA), micro-scale combustion calorimetry (MCC), and microscopy 
were used to assess flammability and coating quality of fire retardant-encapsulated micelle gels. 
After coating, the cotton fabrics were more ignition resistant and, if ignition occurred, the 
coatings self-extinguished. Coated cotton was found to decompose at higher temperatures (150oC 
vs 75oC cotton control). Coating thicknesses resulted in a  >200% mass gain which still requires 
further optimization.  But the combination of flame-retardants packaged in an amphiphilic matrix 
xi 
 
retarded cotton flame ignition. Overall, polyether based amphiphiles have shown as schemes for 
both cisplatin and combinations of flame retardants both of which either have low solubility with 
flame retardants or high systemic toxicity in vivo like cisplatin.  
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CHAPTER I 
 
Background and Motivation 
 
 
1.1  Amphiphilic Triblock Copolymers 
Polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) triblock 
copolymers are amphiphilic block copolymers known commercially as Pluronic surfactants. A 
variety of surfactants are commercially available, with differing hydrophobic block cores (PPO) 
and hydrophilic arm (PEO) lengths ratios. Commercial preparations of Pluronic surfactants often 
contain impurities of the PPO homopolymer, and di- and triblock copolymers with different 
molecular weights and PEO/PPO mass ratio than the desired product [1, 2]. These impurities can 
be removed using gel permeation chromatography (GPC) to selectively filter for polymer chains 
of the desired molecular weight [1, 3].  
1.2  Micellization Process 
Dispersed solutions of Pluronic surfactants will undergo self-assembly, known as 
micellization. Micellization can be achieved by varying concentration at a given temperature, or 
by varying temperature for a given concentration. A schematic of this process is shown in Figure 
1.1 [4].  
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Figure 1.1: Temperature-dependent micellization and gelation of Pluronic surfactants [4].   
 
As the solution crosses the critical micelle temperature (cmt), micelle gels will form and 
an equilibrium balance of micelle gels and dispersed polymer chains will coexist [5, 6]. The 
driving force for micellization is entropic in nature, due to the hydrophobic effect [7], where 
hydrophobic molecules associate with one another in order to dissipate the “water cages” of 
order water molecules that form around each hydrophobic molecule.  
Scientists have previously researched temperature-dependent micellization and ordering 
of PEO-PPO-PEO triblock copolymers in aqueous solutions [8-18]. As the temperature of these 
solutions is increased, the decreasing aqueous solubility of the PPO segments often causes 
micelle formation of hydrophobic (PPO) cores with hydrophilic (PEO) normally forming the 
shells pointed out into aqueous solvent [15]. Lam et al. [17] suggested micelles grow via 
Ostwald ripening and Barba et al. [18] suggested that the volume fraction occupied by the 
micelles in solution rises with increasing temperature. The micelles experience repulsive 
interactions and order into quasicrystalline cubic lattices which give these structures their gel-
like properties [15]. Conventional polymer hydrogels are typically formed via covalent bonding 
formation between adjacent polymer chains (crosslinking), or physical entanglement of multiple 
chains, resulting in a mechanically robust tangled network [19]. In a micelle gel, the lattice 
3 
 
ordering of individual micelles offer mechanical stability [20] because there is no covalent 
bonding in micelle gel formation, and the micellization behavior is driven by temperature or 
concentration; thus making the gelation process reversible.  
1.3  Applications of Micelle Gels 
Micelle gels have found multiple industrial applications as emulsifiers, stabilizers 
lubricators, and detergents [21, 22]. Our group has even experimented with micelle gels as a 
potential use in fire retardant applications, which is outlined in Chapter V [23]. However, micelle 
gels are particularly attractive for use in biomedical applications because of the gels reversible 
temperature-dependent gelation behavior. Biomedical researchers are interested in this reversible 
temperature-dependent gelation behavior because one can use ambient metabolic heating to 
trigger gelation if the gel temperatures of these amphiphiles is sufficiently low [24-28]. These 
solutions can be injected as a liquid at low temperatures, which then form gels in situ as the 
solution warms to body temperature [15]. The rigidity of the gel formation allows one to inject 
drug infused copolymers and after gelation the gel regulates the localized permeation of added 
pharmaceuticals, which might lead to a more sustained delivery and longer local residence time 
[28]. Micelle gels are also biocompatible as they can interact with host tissues with minimum 
concern for cytotoxicity [29]. This delivery strategy is more favorable compared to more 
conventional gels that are liquid at high temperatures and gels at low temperatures because the 
heated fluid from conventional gels (which would gel upon cooling to body temperature) may be 
damaging to surrounding tissues or skin [4]. 
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1.4 Micelles Gels for Chemotherapeutic Applications 
One of the main treatments for both localized and metastatic cancer is chemotherapy, 
which is used in conjunction with surgery and radiotherapy [30]. It is ideal to deliver a sufficient 
quantity of drug to tumorous cells, while minimizing systemic side effects and toxicity. 
However, the drug effectiveness is retarded due to the complications with administering them 
such as inefficient distribution, limited chemotherapeutic solubility, an inability to permeate cell 
membranes, rapid clearance, and the lack of selectivity between normal cells and cancer cells 
[30]. Cis-dichlorodiammineplatinum(II) (cisplatin) is one of the most potent and widely-used 
anticancer drugs for treating testicular, ovarian, bladder, cervical, head, neck, oesophageal, and 
small-cell lung cancers [31, 32]. Cisplatin interacts with DNA and interferes with the normal cell 
transcription and replication processes, resulting in apoptosis [31, 33]. Despite its effectiveness, 
the clinical use of cisplatin and its derivatives is limited due to severe systemic side effects 
including nephrotoxicity, neurotoxicity, ototoxicity, nausea, and vomiting [34]. Therefore, 
developing efficient drug delivery systems that selectively increase the concentration of 
chemotherapeutics in diseased cells and tumors are of great significance and value.        
To increase the therapeutic efficacy, chemotherapeutic drugs are often coupled with 
polymeric micelles and surfactants [35-37]. Blocky amphiphilic copolymers with a large 
solubility difference between hydrophilic and hydrophobic segments are known to assemble in 
an aqueous environment into polymeric micelles with a 10-100 nm size range [38-41]. These 
micelles have a narrow size distribution and are characterized by their core-shell architecture, 
where hydrophobic segments are segregated from the aqueous exterior to form a hydrophobic 
inner core surrounded by hydrophilic segments [35]. Interests in applying block copolymer 
micelles as drug delivery systems have increased because of the high drug-loading capacity of 
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the inner core as well as some level of increased tolerance of the drug loaded micelles compared 
to neat drugs [42-46]. The aggregation and surface properties of polymeric micelles in solution 
depend on external factors such as pH, temperature, pressure, and the presence of additives [47]. 
Thus, the properties of polymeric micelles in solution can be effectively tuned to a desired range 
and application by altering these external factors. Mandal et al. [48-50] has conducted various 
physicochemical studies on PEO-PPO-PEO micelles in sodium dodecyl sulfate (SDS) in the 
absence and presence of various micellized drugs, peptides, and additives as a function of 
various molar compositions using various techniques. Moulik et al. [51] have also recently 
reported about the effect of various additives on aqueous normal and reverse pluronic micelles. 
Therefore, even though there are a variety of structures including microspheres [52, 53], 
dendrimers [54], liposomes [55-58], carbon nanohorns [59-61], carbon nanotubes [30], and 
nanoparticles; gold [62], silver [63], Fe3O4 [64, 65], pH-responsive compounds [66, 67] and 
silica [68, 69]; that can be used as drug delivery agents, polymeric micelles’ high drug-loading 
ability and toxicity shield effect [42-46] suggests they are sufficient drug delivery platforms to 
compliment other used drug delivery materials.  
1.5  Previous Research of Micelle Gels for Drug Delivery 
Research on drug-loaded micelles has included rheology [70, 16], DSC [12, 14, 71, 72], 
SAXS [70, 12, 15], SANS [73, 13], and cloud point determinations [10].  From these, 
assessments of how each perturbant affects the micelle formation temperature are related to the 
drug content and interactions of the drug component within the amphiphile matrix.  Functional 
evaluations of drug loaded micelles have focused on drug release and cell culture studies [74]. 
Sharma et al. [12] studied how adding organics affected the evolution of ordered structures 
forming from PEO–PPO–PEO based solutions as resolved by SAXS. 
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Solutes of greater pharmaceutical significance have also been studied including the 
aggregation of neat forms of commercial PEO-PPO-PEO amphiphilic copolymers produced by a 
range of suppliers including Pluronic F127 (~12,000 g mol-1 molecular mass, 70/% PEO content) 
[75], mixed F127 dispersions formulated with naproxen and indomethacin [11], vancomycin 
[76], lecithin [77], pilocarpine [78], methotrexate [79], and separately lidocaine and prilocaine 
formulated into eutectic mixed micelle solutions of F68 and F127 [80]. Sharma et al. [12] has 
previously studied the effects of two anti-inflammatory agents, naproxen and indomethacin, on 
the lower and upper gelation temperature of F127 solutions. They concluded that the drugs 
shifted both the liquid-to-gel and gel-to-liquid boundaries to lower temperatures and the presence 
of the drug molecules promotes self-assembly of F127 [11], suggesting that different drugs were 
influencing the thermodynamic driving to form the micelle. In their later work they examined the 
gelation of F127 in the presence of a series of hydrophobic pharmaceuticals, to identify any 
correlation between gelation and physicochemical parameters of drug solutes [12].  
1.6  Motivation 
Thermodynamics of micelle and gel formation is relatively well known for a variety 
Pluronic surfacnts. Kinetic or transient effects, however, are less known for specific 
combinations of amphiphilic copolymers with varying hydrophilicity and chemotherapeutic 
drugs. There is a large potential to encounter non-equilibrium transition conditions in real-world 
applications, and more work needs to be done under these conditions. There may be transient 
factors in the formation or properties of micelle gels, and these factors need to be studied in order 
to achieve maximum optimization of micelle formation for a given application. Little is known 
about how the presence of a ternary additive affects the gel properties of amphiphilic micelles 
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with varying hydrophilicity or the mechanism by which enhanced release or delivery profiles are 
achieved.  
The aim of this dissertation work was to provide a more comprehensive study of the 
effects, both microscopically and macroscopically, on the gel formation and properties of 
micelles with varying hydrophilicity. The rationale for understanding how ternary additives 
perturb the micelle formation energetics and where within the micelle ternary additives are 
partitioned is key to resolving how formulated micelles perform as drug delivery vehicles. In this 
dissertation, we attempt to better understand the linkage between forming structures of 
amphiphiles housing other molecules and the effect on availability and performance.  Four main 
methods were used to complete this study: differential scanning calorimetry (DSC), small-angle 
x-ray scattering (SAXS), ultraviolet-visible (UV-Vis) spectroscopy, and flammability testing 
methods. The energetics of micellization and gel formation was probed using DSC. Structural 
studies on the micelle lattices were carried out using SAXS. Diffusion studies and release 
characteristics of the micelle gels were measured using UV-Vis. Vertical flame tests (VFT), 
thermogravimetric analysis (TGA), micro-scale combustion calorimetry (MCC), and scanning 
electron microscopy (SEM) were all used to test for flammability and coating quality of fire 
retardant-encapsulated micelle gels. Efforts were made to explore kinetic effects such as 
increasing heating rates, in order to determine if transient effects play a significant role in gel 
formation. By thoroughly studying the effects of ternary additives on micelle gel formation, a 
more complete picture of the molecular interactions taking place will be developed which will 
lead to a better understanding of ternary additives and their interactions with amphiphilic 
copolymer micelles and gels. This understanding may prove useful in the optimization of 
polymer formulations used in pharmaceutical, biomedical, or other applications.   
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CHAPTER II 
 
Thermodynamic Characterization of Micelle Formation 
 
2.1  Introduction 
The rationale for understanding how ternary additives affect micelle formation energetics 
is key to resolving how formulated micelles perform as drug delivery vehicles. The 
thermodynamic analysis of solubility within a micelle has been presented in the form of an 
enthalpy-entropy compensation, first described by Lumry and Rajender [81]. ΔGmicellization is the 
free energy to take one mole of amphiphile dispersed in solution into the micelle phase and is 
given by [82, 83] 
∆Gmicelliation =  RTmicelleln(cmc)      (2.1) 
Where Tmicelle is the micelle formation temperature, and cmc is the critical micelle concentration.  
The enthalpy is the integral of each micelle formation endotherm.  The entropy of micelle 
formation is extracted from rearranging the Gibbs Helmholtz Equation to yield [82, 83]  
∆Smicelle =
(∆Hmicelle− ∆Gmicellization)
Tmicelle
    (2.2) 
resolved at the micelle formation temperature at each concentration of amphiphile used.  From 
the determinations of ΔSmicelle and ΔHmicelle, a direct plot can resolve both the slope, identified as 
the compensation temperature, Tcompensation, and the intercept (identified as ΔH0).  Cornish-
Bowden [84] explained that the name enthalpy-entropy compensation refers to the idea that 
variations in ΔH that accompany variations in the temperature at which each molecule is 
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normally active are “compensated for” by variations in ΔS. The compensation temperature 
represents the driving force for solute-solute and solute-solvent interactions [14, 81-83, 85-96] 
and has been identified for neat amphiphiles in solution [71, 97] and ionic liquids such as the 
Gemini surfactants [98]. According to Jolicoeur et al. [99, 100], since hydrophobic interactions 
contribute largely to micelle stability, a general enthalpy-entropy correlation yields a 
compensation value characteristic of such interactions [90]. Chen et al. [101, 81] explained for a 
compensation phenomenon, the micellization could be described as consisting of a two-part 
process: (a) the “desolvation” part, i.e., the dehydration of the hydrocarbon tail of surfactant 
molecules, and (b) the “chemical” part, i.e., aggregation of the hydrocarbon tails of surfactant 
molecules to form a micelle.   
In terms of probing the origins of what is meant by solute-solute and solute-solvent 
interactions, it might also be worth resolving how micelle formation and subsequent ordering of 
them regulate the solution thermodynamics.  Consider the driving force for forming spherical 
micelles in solution from neat amphiphilic copolymers.  Goldstein has suggested that the driving 
force for forming micelles suggests that it can be idealized as a spherical core (with a volume of 
a sphere) with the hydrophobic sections binding together to form an agglomerate of constant 
density [102].  That suggests that there is an enthalpy for forming this organized structure as 
ΔHmicelle core.  Goldstein also points to the co-location of the hydrophilic sections that are bonded 
to the center blocks and are conveyed to an interface contributing to a core-shell interfacial 
energy [102]. Like Goldstein’s analysis, a more detailed analysis would include contributions 
linked with the lengths of the different blocks [102].  In addition, if the phase separation to 
cluster the hydrophobic sections is the main driving force for micellization, there may be small 
contributions to the free energy associated with the energetics of forming the shell and the 
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interface between the shell and the surrounding aqueous solution.  This would lead to four terms 
contributing to the free energy of micelle formation, as shown in Equation 2.3.  
∆Gmicelliation = Vcore ∆Hmicelle core + SAc−sσc−s +  Vshell∆Hshell + SAshell σshell  (2.3) 
For an amphiphile that forms a sphere, Vcore is the volume of the hydrophobic core and 
the first interface encountered from the micelle center is the core-shell (c-s) interface where the 
hydrophilic ends are pointed out into the aqueous phase. The interface region between the 
hydrophobic and hydrophilic regions will create a surface energy term; called c-s with the total 
energy of this term linked with the surface area (SA) of the interaction, in this instance a sphere. 
The larger the enthalpic payoff for driving these block copolymers together into forming 
micelles, the hydrophobic blocks take their hydrophilic ends with them and there is a need to 
situate the hydrophilic chain ends in the most entropically favorable arrangement, which is much 
more constrained than when dispersed in solution. At the boundary where the shell interacts with 
the aqueous medium, there is a separate interfacial energy, shell term, also linked with the 
surface area of that interaction, SAshell.  
As a function of radial dimensions, Equation (2.3) can be rearranged in the dilute micelle 
region (no micelle-micelle interactions, just discrete micelles in solution) as  
∆𝐺𝑚𝑖𝑐𝑒𝑙𝑙𝑖𝑎𝑡𝑖𝑜𝑛 =
4
3
π𝑟3
 
∆𝐻𝑚𝑖𝑐𝑒𝑙𝑙𝑒 𝑐𝑜𝑟𝑒 + 4π𝑟
2𝜎𝑐−𝑠@𝑟 +  
4
3
π(𝑅3 − r3)∆𝐻𝑠ℎ𝑒𝑙𝑙 + 4π𝑅
2𝜎𝑠ℎ𝑒𝑙𝑙  (2.4) 
where r is the radius of the hydrophobic core, R is the radius of the entire micelle including the 
swollen shell, c-s corresponds to the surface energy between the core and shell, and 𝜎𝑠ℎ𝑒𝑙𝑙 is the 
surface energy between the micelle and the aqueous medium from which the micelles formed.  
For block copolymers, there is the discrete linkage between the driving force to cluster 
hydrophobic blocks together and the corresponding entropic penalty that arises since the 
hydrophilic ends are constrained by the covalent bonding to the core.  
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Any drug that is absorbed into the micelle core or shell could migrate within the core-
shell structure and probably has its largest effect in regulating the surface energy between the 
core and the shell.  Small molecules that are substantially more hydrophobic might swell the 
micelle core, but large-scale swelling of micelles has not been observed. If the small molecules 
were substantially more hydrophilic, they would be influencing the Hshcll term, which is small, 
or they could swell the shell. The suggestion that there is interplay between the enthalpic driving 
forces to form well-defined structures in solution is offset by the constraint of what volumes the 
tail sections of the block copolymer is the origin of the compensation temperature. That small 
molecules can regulate the compensation temperature is an acknowledgment that their 
distribution controls the contributions to the free energy found in Equation (2.4). 
It is also thought that a deviation in the compensation temperature from neat solutions is 
a useful indicator of drug loading interactions with an amphiphile if the ternary constituent is 
strongly interacting with it. Ravi et al. [103] proposed at the compensation temperature the 
enthalpy and entropy changes fully compensate one another, and there is no change in G upon 
changing the reactant [103]. Similar compensation temperatures for systems may mean that the 
processes occurring in the different systems are the same, but the mechanisms of the processes 
may still be different [103]. Therefore, if the two processes are have identical compensation 
temperatures, then the fraction of the total free energy arising from the enthalpy contribution is 
the same in both processes [103]. If the compensation temperatures are different, then the 
mechanisms of the two processes must be different [103]. Mechanisms meaning the ways in 
which solutes are retained i.e. location of retention or driving force of retention and 
intermolecular forces [103]. Resolving how a drug mimic also affected the compensation 
temperature has been done in our study [72] outlined in this chapter with methylparaben and 
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Pluronic P105. This chapter also outlines our evaluation of the thermodynamics of micelle 
formation using Pluronics L101, P104, P105, and F108 solutions and cisplatin as a ternary 
additive [104].  
Our group has previously evaluated the enthalpy and structural changes in F127 micelles 
by several methods [16, 15] . We showed that neat F127 solutions formed micelles more 
abruptly suggesting a nucleation-based mechanism. Methylparaben, co-formulated as an anti-
fungal constituent in topical creams, was found to soften the transition such that ordered micelle 
formation occurred at lower temperatures and the size of the enthalpy grew more systematically 
with changes in temperature [16, 15]. In an attempt to span a wider range in sequestration 
behavior between strongly hydrophobic and strongly hydrophilic amphiphiles, we report on 
research results on the enthalpy and structural changes that occur in the amphiphiles L101 
(~3,800 g mol-1 molecular mass, 10/% PEO content), P104 (~5,900 g mol-1 molecular mass, 40% 
PEO content), P105 (~6,500 g mol-1 molecular mass, 50% PEO content), and F108 (~14,600 g 
mol-1 molecular mass, 80% PEO content) both in the neat state and when mixed with the 
hydrophilic drug cisplatin [cis-dichlorodiammine-platinum (II)]. 
There has been common interest in resolving how adding other, more potent drugs like 
chemotherapeutics affected micelle structure and formation characteristics.  Among them were 
platinum-based chemotherapeutics such as cisplatin, carboplatin (cis-diammine (1,1-
cyclobutanedicarboxylato)) platinum, and oxaliplatin (cis-[1R,2R-cyclohexanediamine-N,NV] 
[oxalato(2-)-O,OV]) platinum that are often used in treating bladder, cervix, lung, ovarian and 
colorectal cancers [105, 106]. Prior clinical work characterizing the effects of three Pluronic 
triblock copolymers (from hydrophilic F127, through P85, and to the more hydrophobic L61) has 
examined on the cytotoxicity of carboplatin to a rat colorectal carcinoma cell line [107].  Other 
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efforts to package chemotherapeutics directly as drug-infused micelles for vascular delivery have 
also been using cisplatin in F127 [108].  
Other efforts have explored how mixing aqueous polymeric micelles with different drugs 
helps in nanoscale drug delivery [109], polymeric micelles for cancer chemotherapy [110], PC-
14 cells treated with cisplatin-incorporated polymeric micelles [111], drugs in block copolymer 
micelles [112], multidrug-resistant human ovarian carcinoma cells by P85 [113], micelles in 
anticancer drug delivery [114], cisplatin-incorporated polymeric micelles treated on tumors in 
mice [37], polymeric micelles for delivery of poorly water-soluble compounds [115], targeting, 
imaging, and triggered release of micelles in anticancer therapy [116], sized controlled polymeric 
micelles containing cisplatin [117], and hydrogels from cisplatin-loaded block copolymers in 
drug delivery [118]. These studies show the importance of exploring chemotherapeutic drugs 
like cisplatin when mixed with PEO-PPO-PEO copolymers. In this chapter, we look to study 
how cisplatin is partitioned into PEO-PPO-PEO copolymers from the thermodynamic side.   
If the presence of a chemotherapeutic alters the driving force for micelle formation, one 
would naturally conclude that solute-solvent interactions are controlling features in regulating 
micelle formation. As a result, it seems reasonable to probe the impact on the compensation 
temperature by perturbing the thermodynamics through the addition of small molecule 
chemotherapeutics in these structures. We report in this chapter on our efforts to use the 
hydrophilic perturbant cisplatin into a range of PEO-PPO-PEO copolymers of varying 
hydrophilicity, as determined by a calorimetric assessment of both the critical micelle formation 
composition and the size of endotherms measured as temperatures are varied.  
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The experiments, results, and discussion covered in this chapter were submitted and 
published in the Journal of Colloid and Interface Science [72] and Journal of Thermal Analysis 
and Calorimetry [104]. 
2.2  Materials and Methods 
PEO-PPO-PEO (Pluronic P105, Pluronic P104, Pluronic L101, Pluronic F108: BASF 
Wyandotte MI) were obtained and used as received. Aqueous solutions of L101, P104, P105, and 
F108 were each prepared according to “cold” processing methods [29] and formulated in varying 
concentrations to probe the enthalpy of micellization. Methylparaben (Sigma-Aldrich) was added 
to aqueous solutions of varying P105. Two types of formulation protocols were created for P105 
and methylparaben. One fixed the P105 content and varied the amount of methylparaben. The 
other scheme used a fixed amount of methylparaben and varied the P105 content. Cisplatin 
(Sigma-Aldrich) was added to aqueous solutions of varying Pluronics (L101, P104, P105, F108).  
The structures of methylparaben, cisplatin, and the polymers are shown in Figure 2.1 [72, 
104]. Two types of formulation protocols were followed for cisplatin and the copolymers. One 
varied each copolymer (L101, P104, P105, and F108) content in solution from 2% mass v-1 to 
10% mass v-1 in 2% mass v-1 increments. The other scheme fixed each Pluronic (L101, P104, 
P105, and F108) content at 10% mass v-1 and varied the amount of cisplatin in solution from 0% 
mass v-1 to 0.1% mass v-1 in 0.02% mass v-1 increments. 
As dispersions were produced, aliquots were extracted by syringe, deposited into DSC 
pans, and tested using a TA Instruments Q-2000 DSC.  Tests were conducted under nitrogen 
purge while the temperature was ramped from 0-40C at 10C min-1, typical of other heating 
rates measures for other amphiphilic copolymers since the micelle forms between the 20C and 
30C range.  At least three replicates were evaluated per formulation.   
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The onset and peak temperatures and the size of the endotherm were determined from the 
heat flow curve. As the contents of each Pluronic were lowered (L101, P104, P105, and F108), 
the micellization endotherm shrunk and at some concentration, no endotherm was observed 
indicating the concentration was below the critical micellization concentration (cmc).   
Figure 2.1: (a) Examples of Pluronics F108, P105, P104, and L101 (b) example of PEO-PPO-
PEO micelle structure (c) methylparaben (d) cisplatin [72, 104]. 
 
2.3 Results and Discussion 
2.3.1 DSC Results for Neat Micelles in Aqueous Solution 
The influence of amphiphilic copolymer P105 content by DSC is noted in Table 2.1 and 
Figure 2.2 [72]. The temperature of the peak in the micelle formation is shifted slightly to lower 
temperatures (~2oC) by adding more copolymer to solution. The enthalpy is also reduced with 
less P105 in solution since there are fewer micelles that can form in more diluted mixtures of 
amphiphile in solution above the cmc.  
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Table 2.1: DSC results for 4-10% P105 in H2O. Larger P105 concentrations show both a lower 
Tmicelle and a larger H on a per gram basis [72].  
P105 concentrations 
(%mass v-1 ) 
∆𝐻  
(J/g) 
Micelle Formation Temperature 
(⁰C) 
2.0 0.81 ± 0.06 23.5 ± 0.07 
4.0 1.96 ± 0.05 21.2 ± 0.11 
6.0 3.27 ± 0.29 19.2 ± 0.08 
8.0 3.68 ± 0.14 18.5 ± 0.04 
10.0 4.09 ± 0.18 18.3 ± 0.2 
 
  
Figure 2.2: Increasing the concentrations of P105 in water also increased the enthalpy (H) [72]. 
 
2.3.2  Critical Micelle Concentrations 
As the concentration of amphiphilic copolymer is diluted, there are some minor 
distortions in the H peak shape. At a low enough concentration, the micelle endotherm is not 
observed, as shown in Figures 2.3-2.6. The driving force is insufficient to form micelles below 
some threshold and that demarcation we note here as the cmc.  
Figure 2.3 shows the concentration dependence of P105; the endotherm is suppressed at 
0.4% mass v-1 [72]. The P105 cmc we resolved by DSC is slightly higher than that observed by 
Alexandridis et al. [119, 120] (0.3% mass v-1) using UV-visible absorption spectroscopy at 25oC 
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[119, 120]. For the larger thermodynamic analysis we used the cmc determinations from 
Alexandridis et al. [119, 120] for determining S and G although similar trends arise using the 
cmc resolved by DSC. 
     
 
 
 
 
 
 
 
 
 
Figure 2.3: DSC results at P105 content: the critical micelle concentration (cmc) of neat Pluronic 
P105 was noted between 0.2% and 0.4% mass v-1 [72]. 
 
 Figure 2.4 shows the concentration dependence of P104; the endotherm is suppressed at 
~0.5% mass v-1 at ~24.5oC [104]. The P104 cmc we resolved by DSC is slightly higher than that 
observed by Alexandridis et al. [10, 9] (0.3% mass v-1) using UV-visible absorption spectroscopy 
at 25oC.  
18 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.4: DSC results at low P104 content: the critical micelle concentration (cmc) of neat 
Pluronic P104 was noted at ~0.5% mass v-1 at ~24.5oC by DSC [104]. 
 
 It makes sense that the cmc for P104 is similar to that of P105 because the ratio of 
hydrophilic (40% PEO) to hydrophobic (60% PPO) molecules is similar to that of P105’s ratio 
(50% hydrophobic to 50% hydrophilic). 
Figure 2.5 shows the concentration for L101; the endotherm is suppressed at ~3.0% mass 
v-1 at ~12.5oC [104].   
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Figure 2.5: DSC results at low L101 content: the critical micelle concentration (cmc) of neat 
Pluronic L101 was noted at ~3.0% mass v-1 at ~12.5oC by DSC [104]. 
 
 It makes sense that the cmc for L101 is at a higher concentration than the cmcs of both 
P104 and P105 because there is a larger hydrophobic region (40% PPO) compared to the 
hydrophilic region (10% PEO) that forces the micelle to form at higher concentrations.  
 Figure 2.6 shows the concentration dependence for F108; the endotherm is suppressed at 
~4.0% mass v-1 at ~29.4oC [104]. The F108 cmc we resolved by DSC is slightly lower than that 
observed by Alexandridis et al. [10, 9] (4.5% mass v-1) using UV-visible absorption spectroscopy 
at 25oC.  
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Figure 2.6: DSC results at low F108 content: the critical micelle concentration (cmc) of neat 
Pluronic F108 was noted at ~4.0% mass v-1 at ~29.4oC by DSC [104].  
 
It makes sense that the cmc for F108 occurs at a higher concentration than the cmc’s of 
both P105 and P104 because the ratio of hydrophilic (80/% PEO) to hydrophobic (20/% PPO) 
molecules is so far apart that the micelle is unable to form at lower concentrations. This would 
help explain why the cmc for L101 also occurs at a high concentration of 3.0% mass v-1 because 
the ratio of hydrophilic to hydrophobic is so far apart. We would expect the cmc for the more 
hydrophilic polymer, F108, to have a higher cmc than the more hydrophobic polymer, L101, 
because the aqueous solution in which it is suspended helps create a favorable environment 
where the micelle can form much easier at a higher concentration. 
For the larger thermodynamic analysis, we used our cmc values of each copolymer for 
determining S and G. To address the question of how ternary additives affect the 
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thermodynamics of micelle formation, extractions from the low to high concentration regimes 
allow the determination of G and direct measurements of the enthalpy of micellization. From 
these measurements, thermodynamic plots of H-S can be produced both in a neat state and in 
the presence of methylparaben or cisplatin. Figures 2.8-2.10 show the enthalpy-entropy 
compensation plots for P105 and P104, for their neat states and are compared to each amphiphile 
solution mixed with methylparaben or cisplatin. Two types of behaviors were observed with, a 
cisplatin-influenced compensation temperature profile (P104) and a cisplatin-insensitive 
compensation temperature profile (L101, P105, and F108). 
 
2.3.3  Effect of Methylparaben on Micelle Formation Energetics 
Figure 2.7 shows how adding methylparaben (MP) to 10% P105 solutions with 
increasing amounts of MP affected H, which changed from 350.8 to 318.2 kJ mol-1 when 
increasing amounts of MP was added up to 1% mass v-1 [72]. The presence of MP modulates the 
interaction energy of the mixtures and reduces the size of both the micelle formation endotherm 
and its peak temperature.  A similar suppression was noted by Bouchemal et al. [121] who 
characterized 1,2 propanediol in F127 and noted a ~20% smaller endotherm when added as 
much as 2.3 w/v%.  Kelarakis noted the near athermal micellization in other diblocks [122, 123].  
If ternary compounds raise structural disorder, the enthalpy contribution to micelle formation 
should be reduced. 
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Figure 2.7: Increasing concentrations of MP in 10% P105 reduces both the Tmicelle and H [72]. 
Standard deviation less than 0.05 for all points, therefor error bars are too small to be shown 
given the scale of the y-axis.    
 
At higher concentrations relative to the P105 solution concentration, the presence of MP 
cannot suppress micelle formation. 80% of the original endotherm is still observable in 10% 
P105 with 1% MP.   
The larger question overall is how the relative impact of the ternary additive affects the 
thermodynamics. To address this question, extractions from the low concentration regime allow 
the determination of ΔG and direct measurements of the enthalpy of micellization. From these 
measurements, thermodynamic plots of ΔH-ΔS can be produced both in a neat state and in the 
presence of MP.    
Figure 2.8 is the enthalpy-entropy compensation plot for neat P105 (grey squares) that 
yields a compensation temperature of 294 K [72].  The compensation temperature determined for 
23 
 
neat P105 is very similar to that resolved for the 8-series of Pluronic (e.g. F68, F98) of 291.2 K 
[124].  Adding MP to the mixture triggers a rise in the compensation temperature from 294 K to 
328 K (blue circles) treated as a separate dataset.  
Figure 2.8: The enthalpy-entropy (H-S) compensation plot for P105, solutions both neat (grey 
squares) and co-formulated with MP (blue circles) [72]. Upper and lower bounds for neat P105 
(yellow line slope = 297 K, and red line slope = 281 K respectively) and co-formulated with MP 
(blue line slope = 340 K, and green line slope = 317 K) represent 95% confidence intervals.   
 
 If the compensation temperature represents solute-solvent interactions, then the slopes of 
the H-S curves with and without ternary additives should be different. It seems appropriate 
that adding a ternary species might influence the energetics of micelle formation. We compared 
our results to published work by Bouchemal et al. [14] who using 1,2-propanediol with F127 
using Isothermal Titraction Microcalorimetry. Interestingly, by using separate temperature 
compensation slope determinations, we observe from their results a similar rise in the 
compensation temperature from 293.3 to 316.5 K when co-formulated with 1,2-propanediol [14]. 
Their original analysis reported a mean Tcompensation of 298.1 K [14]. 
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2.3.4  Effect of Cisplatin on Micelle Formation Energetics 
 Figure 2.9 is the enthalpy-entropy compensation plot for neat P105 that yields a 
compensation temperature of 289 K [104]. This determination is similar to that resolved for other 
PEO-PPO-PEO micelle structures (F108, F98, F88, F68, F38, and P65) of 291.03 K [71], 294.9 
K for F88 and F68 [92], 293.3 K for F127 [14], 281 K for 12 Pluronics [91], between 280-298 K 
for a range of copolymers [93], 285 K for series of hydrocarbons [81], 293.9 K for neat P105 
determined by an averaging algorithm [72], and 287 K through 319 K on 23 amphiphile systems 
[94].  Here we found that adding cisplatin to P105 was within range of the compensation 
temperature for neat P105. If there is an interaction between P105 and cisplatin, the energetics of 
the new interactions are not influencing the structure. This observation makes sense if the 
cisplatin is more bound in the aqueous solution and not interacting strongly within then micelle. 
We observed similar behavior for other PEO-PPO-PEO copolymers that were both more (F108) 
and less (L101) hydrophilic and found similar statistical insignificance of cisplatin on the 
modified compensation temperature.   
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Figure 2.9: The enthalpy-entropy (ΔH-ΔS) compensation plot for P105, both neat (blue triangle) 
and co-formulated with cisplatin (orange squares) [104]. Upper and lower bounds for neat P105 
(grey line slope = 297 K, and yellow line slope = 281 K respectively) and co-formulated with 
cisplatin (blue line slope = 290 K, and green line slope = 288 K) represent 95% confidence 
intervals.   
 
 Figure 2.10 is the enthalpy-entropy compensation plot for neat P104 that yields a 
compensation temperature of 302 K [104]. The P104 compensation temperature is higher 
compared to the other copolymers investigated as part of this study, but similar to that resolved 
for ionic surfactants of 319 K [90], Tetronic T904 in Na2SO4  (317.9 K) [93], 328.43 K for P105 
co-formulated with methylparaben [72], and 287 K through 319 K on 23 amphiphile systems 
[94]. Adding cisplatin to the mixture reduces the compensation temperature from 302 K to 289 
K, typical of the other PEO-PPO-PEO mixtures [14, 71, 72, 81, 91, 93, 94]. We attribute the 
compensation temperatures decrease in drug-loaded P104 condition to a larger interaction 
between cisplatin and the copolymer structure. Lee et al. [85] indicated that when the addition of 
a solute decreases both the enthalpy and entropy, this indicates a lowering of solution 
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hydrophobicity and is a characteristic of solute-solute and solute-solvent interactions. It is 
conceivable that cisplatin is more situated at the core/shell interface which would likely lead to a 
larger thermodynamic effect. If the cisplatin was less effective at changing the compensation of 
the other mixtures, then we assume that the drug is more fully engulfed in the corona or in 
solution, thus not affecting the hydrophobicity of the overall solution. 
 
Figure 2.10: The enthalpy-entropy (H-S) compensation plot for P104, both neat (blue squares) 
and co-formulated with cisplatin (orange circles) [104]. Upper and lower bounds for neat P104 
(grey line slope = 308 K, and yellow line slope = 296 K respectively) and co-formulated with 
cisplatin upper and lower bounds (blue line slope = 291 K, and green line slope = 287 K 
respectively) represent 95% confidence intervals.   
 
 
A summary of the enthalpy-entropy compensation temperatures for all the PEO-PPO-
PEO copolymers we have studied (P105, P104, F108, L101) in both the neat states and co-
formulated with cisplatin, along with corresponding correlation values (R2), are presented in 
Table 2.2 [104]. A summary of our cmc values compared with others are also included.  
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Table 2.2 Copolymer cmc values, compensation values, and correlation values of neat and co-
formulated with cisplatin [104]. Each compensation temperature was tested to determine whether 
the slopes were statistically significantly different from one another with a 95% confidence 
interval. 
PEO-PPO-
PEO 
Copolymer 
type 
cmc/% mass 
v-1 by DSC 
cmc/% mass v-1 
by Cloud Point  
Neat 
compensation 
temperature (K) 
 
R2 Cisplatin-
modulated 
compensation 
temperature (K) 
R2 
P105 0.4% 0.3% [10] 289 CI [281, 297] 0.9978 289 CI [288, 290] 0.9999 
P104 0.5% 0.3% [10] 302 CI [296, 308] 0.9988 289 CI [287, 291] 0.9998 
F108 4.0% 4.5% [10] 297 CI [292, 298] 0.9998 296 CI [294, 297] 0.9998 
L101 ~3.0%   283 CI [281, 285] 0.9999 284 CI [281, 287] 0.9996 
 
Along with P105, the compensation temperatures for L101 and F108 also showed very 
little changes from the neat states to the cisplatin-loaded states, which suggests that cisplatin 
does not seem to affect the energetics of micelle formation in the copolymers. Cisplatin is likely 
fully contained in the hydrophilic regions of each dispersion.   
Since the compensation temperature represents solute-solvent interactions [14, 81-83, 85-96], 
then the slopes of ΔH-ΔS curves with and without ternary additives should be different if the 
ternary constituent interferes with energetics of micelle formation.  As observed in our previous 
study with methylparaben [72], adding a ternary species influenced the energetics of micelle 
formation. Here, we observe a compensation temperature invariance adding cisplatin to P105, 
F108, and L101. The invariance suggests that the energetics of micelle formation are not being 
influenced by the presence of cisplatin.  Instead, we only observed a change in the energetics of 
micelle formation adding cisplatin to P104, which is more similar to our observations with 
methylparaben and F127 [16, 15].  
A schematic of cisplatin sequestration within micelles is provided in Figure 2.11 [104]. 
Cisplatin is considered to be hydrophilic due to its polarity, but Ng et al. [125] has referred to it 
as being moderately hydrophilic. As such, it is postulated that cisplatin is found both distributed 
within the corona and at the core-shell interface. There have been other efforts to conjugate and 
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alter the cisplatin binding within the micelle, following work by Desale et al. [126], who used an 
anionic glutamic acid block to coerce cisplatin more comprehensively to the core-shell 
interphase separating the hydrophilic and hydrophilic blocks. The moderate hydrophilicity of 
cisplatin might help explain why in the DSC we only observed a variation in the compensation 
temperature with and without cisplatin for P104. There is something about the ratio of 
hydrophilic to hydrophobic segments for P104 that interacts with cisplatin and affects the 
energetics. The key experiment is to perform controlled scattering studies to identify exactly 
where within micelles the platinum beacons are situated on average. The presence of cisplatin is 
essentially a perturbant in the micelle and if it disrupts the organization of the micelle, it seems 
plausible that the energetics of micelle formation might be suppressed if the payoff for forming a 
micelle comes with the penalty of distributing the cisplatin within the formed micelle.   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11: Schematic showing how cisplatin is distributed within micelles portioning between 
the PEO corona and the core-shell interface with PEO-PPO-PEO Pluronic P104 [104]. 
 
 
 
 
= cisplatin 
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2.4  Conclusions 
 
We have probed how MP and cisplatin affects PEO-PPO-PEO micelle formation in the 
low concentration regime to identify a critical micelle concentration and at higher concentrations 
co-formulated with MP and cisplatin.  The critical micelle concentrations found for the 
copolymers we tested were similar to those from previous work [72, 10, 9]. Increasing P105 
from 4% to 10% reduced Tmicelle and raised the endotherm. We propose that the enthalpy-entropy 
compensation plot for neat and MP or cisplatin-loaded solutions of amphiphilic copolymers can 
resolve the perturbation in the micelle formation energetics due to the additive. The Tcompensation 
values found here have also been compared to measurements from previous works [14, 71, 72, 
81, 90-94]. The use of temperature compensation plots is an indicator of surfactant quality in 
formulated dispersions coerced into directed assembly.  Tcompensation was essentially invariant 
adding cisplatin to the highly hydrophobic copolymer (L101), the hydrophilic copolymer (F108) 
and had a profound effect on the more amphiphilic P104.  These results might help explain 
where within amphiphilic copolymer micelles various drugs of a certain hydrophilicity are 
situated if cisplatin is partitioned to the core-shell interface of the micelle. The large difference in 
the behavior of Tcompensation between P104 and P105 belied their subtle difference in the structure, 
which was not anticipated as the Tcompensation for P105 was also invariant by adding cisplatin.  Our 
findings present a rationale for explaining how the presence of ternary additives, like MP and 
cisplatin, interacts thermodynamically with forming micelles and the potency of the interaction 
between drug and micelle might regulate drug bioavailability. 
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CHAPTER III 
 
Structural Analysis of Micelle Formation 
 
 
3.1  Introduction 
It is known that ternary additives can influence the aqueous micellization and gelation 
behavior of PEO-PPO-PEO amphiphiles [15, 16, 72, 104]. Methylparaben, for example, lowers 
the gelation temperature of the amphiphile F127 solution by as much as 10-15oC [12, 16]. A 
structural evaluation is important to understand the structure-property relationship that exists in 
these pharmaceutical loaded amphiphile formulations. 
In the previous chapter, we probed how cisplatin affects the PEO-PPO-PEO micelle 
formation in the low concentration regime to identify a critical micelle concentration and at 
higher concentrations co-formulated with cisplatin [104]. We proposed that the enthalpy-entropy 
compensation plots for neat and cisplatin-loaded solutions of amphiphilic copolymers can 
resolve the perturbation in the micelle formation energetics due to the additive [104]. The use of 
temperature compensation plots is an indicator of surfactant quality in formulated dispersions 
coerced into directed assembly [104]. Tcompensation was essentially invariant adding cisplatin to the 
highly hydrophobic copolymer L101, the hydrophilic copolymer F108, and the more amphiphilic 
copolymer P105, but cisplatin had a profound effect on the more amphiphilic P104 [104].  
Our group has previously investigated the effect of heating rate on the gelation of both 
F127 and F127-methylparaben solutions and found that not only does the presence of 
methylparaben lower the gelation temperature; it also accelerates the gel transition [16]. We also 
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previously used small-angle X-ray scattering (SAXS) to investigate the crystalline structure of 
F127 solutions as they are heated through their gelation temperatures both neat and co-
formulated with methylparaben and dexamethasone [15]. We found that the presence of 
methylparaben and dexamethasone facilitates or enhances the structural ordering, allowing 
ordered phases to emerge at lower temperatures and remain at higher temperatures as compared 
to the neat F127 solutions [15]. However, the gelation kinetics of amphiphiles P104, P105, and 
F108 as they interact with a ternary additive like cisplatin is less well known. A more direct 
evaluation of structural evolution is needed to better understand the transition from the 
disordered to the ordered state for P104, P105, and F108.  
SAXS and SANS scattering have been used previously to study the structure and 
organization of micellar systems [1, 5, 127, 128, 15], including P104 [129-141], P105 [142-147], 
and F108 [148-156]. These techniques allow insight into both the structures within the micelles 
and the lattice structures into which they arrange. Svensson et al. [135] noticed SAXS diffraction 
patterns for P104 in the normal micellar liquid crystalline phase, I1, composition 31% mass v-1 at 
25oC. Using DSC, we also noticed P104 was profoundly influenced by the presence of cisplatin 
that must influence the core-shell interface between the hydrophobic and hydrophilic regions of 
the micelle [104]. In this chapter, we use SAXS to investigate the crystalline structure of P104, 
P105, and F108 solutions as they are heated through their gelation temperatures. Our aim is to 
identify changes in quasicrystalline lattice formation as an effect of added pharmaceuticals, and 
resolve whether cisplatin is located within the micelles’ core, shell, core-shell interface, or 
randomly dispersed in solution. We also observe structural changes associated with the presence 
of cisplatin on P104, P105, and F108 and examine the different kinetics of gel formation with 
varying core-shell dimension. With the complications for therapeutic delivery linked with the 
33 
 
limited solubility of hydrophobic drugs, key features in bioavailability could be linked to the 
thermodynamic mixing drug and amphiphile combinations.  
The experiments, results, and discussion covered in this chapter are in final preparations 
to be submitted for review [157]. 
3.2  Materials and Methods 
3.2.1  Solution Preparation 
Pluronics P104, P105, and F108 were obtained from BASF (Wyandotte, MI) and used as 
received. Aqueous solutions of 31% mass v-1 P104, P105, and F108 were each prepared 
according to the “cold” processing method of Schmolka [29] by dissolving weighed amounts of 
each amphiphile into distilled water, which were then left to solubilize quiescently at 4oC. At this 
high concentration, repeated cool/mix cycles were needed to fully solubilize the polymers. 
Cisplatin (Sigma-Aldrich) was used as received and added to aqueous solutions of these varying 
Pluronics (P104, P105, F108). 
Two types of formulation protocols were followed. One fixed each Pluronic (P104, P105, 
and F108) content and cisplatin content at 31% mass v-1 and 0.1% mass v-1 respectively, to 
investigate the structures formed in both neat and co-formulated with cisplatin to study both the 
progressive evolution and breakdown of these structures as the temperature is increased from 
10oC to 35oC. To see if cisplatin affects the kinetics of micelle and gel formation temperatures as 
a function of concentration, we also fixed P104 (31% mass v-1) and varied the cisplatin 
concentrations from 0.02% to 0.1% mass v-1 in 0.02% increments through 10oC to 35oC.  
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3.2.2  Small-Angle X-Ray Scattering (SAXS) 
SAXS experiments were conducted at Argonne National Laboratory (Argonne, IL) at the 
Advanced Photon Source (APS) on beamline 12-BM-B operating at 12 keV. Static heating tests 
were used to probe the structure at a series of discrete temperatures between 10oC and 35oC. 
Each sample was aliquoted into thin-walled capillary tubes (0.01 mm wall thickness) and 
simultaneously placed into the heating stage illumination. Each sample was subjected to a 1-
minute equilibration time at 10oC to ensure the sample temperature was uniform and steady. 
Scattering data was collected for each sample for 1 minute. After measuring each sample at the 
corresponding temperature, the heating stage ramped up 2oC, followed by a subsequent 1-minute 
equilibration, then re-exposed again for 1 minute. This process was repeated until 34oC was 
reached. During the heating and equilibration phases, the X-ray shutters were closed to avoid 
unnecessary exposure to the beam. The starting and final temperatures were chosen to be well 
below and above the gelation temperature of the sample, respectively from prior determinations 
of the critical micelle concentrations of P104, P105, and F108 using DSC [72, 104]. 
3.2.3  Data Collection and Analysis 
2D SAXS data were collected. The data was integrated around the azimuthal axis to 
generate 1D plots of the measured intensity as a function of the scattering vector q using 
SASView. Peak positions in the generated I (q) plots were quantified using OriginLab’s peak 
analyzer function. These peaks were then compared to the expected reflections for the various 
known crystal structures in order to identify the structures present in the solution. Table 3.1 [157] 
presents a summary of the first five peaks and their positions relative to the fundamental 
scattering peak for the fcc and bcc crystal systems [15].  
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Table 3.1: Summary of expected peaks and relative peak positions for the bcc and fcc crystal 
systems 
Crystal q0 q1 q2 q3 q4 
bcc (110) (200) (211) (220) (310) 
position q0 2
1/2 q0 3
1/2 q0 4
1/2 q0 5
1/2 q0 
fcc (111) (200) (220) (311) (222) 
Position q0 (4/3)
1/2q0 (8/3)
1/2 q0 (11/3)
1/2q0 (12/3)
1/2q0 
 
The size of a cubic unit cell 𝑎, can be obtained by plotting (q/2π)2, where q is the scattering 
vector, versus the Miller indices (h2 + k2 + l2) of the cubic structures, according to Equation (3.1) 
[140]. 
(q/2π)2 = (1/𝑎)2(h2 + k2 + l2)     (3.1) 
At the APS beamline 12-BM-B, 12 keV of beam energy was used allowing us to solve for 
frequency, ν, in Equation (3.2).  
E = hν       (3.2) 
Where E is energy of the beam and h is Planck’s constant. Using frequency, ν, and speed of light, 
c, Equation (3.3) can be used to solve for the wavelength, λ, of the X-rays.  
λ = 
𝑐
𝑣
        (3.3) 
The relationship between q and theta for SAXS is identified in Equation (3.4) where 2θ is the 
angle between the incident X-ray beam and the detector measuring the scattering intensity. 
q = 
4π sin(θ)
       λ
      (3.4) 
Using Bragg’s law, Equation (3.5) can be used to solve for the spacing, d, between adjacent (hkl) 
lattice planes. 
d = 
λ
2sin(θ)
      (3.5) 
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Finally, using the spacing, d, for cubic crystals as length, L, and the change in temperature, ΔT, 
assuming negligible effect of pressure, the linear thermal expansion coefficient, αL, can be 
calculated with Equation (3.6).  
αL = 
∆L
𝐿∆T
      (3.6)  
where L is the original length, and ΔL/ΔT is the rate of change of the linear dimension per unit 
change in temperature.  
3.3  Results and Discussion 
3.3.1  Phase Structure Identification 
Figure 3.1 [157] compares the presence of ordered phases for neat P104 (31% mass v-1) 
and P104 mixed cisplatin (0.1% mass v-1) at 28oC with peak identifications. Crystal structures 
were determined based on their ratio to the fundamental peak. A full list of peak positions and 
phase structure for neat P104 (31% mass v-1) and cisplatin mixed P104 (0.02%-0.1% mass v-1) at 
28oC is listed in Table 3.2 [157].   
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Figure 3.1: Comparison of peak identifications of neat P104 (31% mass v-1) and P104 mixed 
cisplatin (0.1% mass v-1) at 28oC [157]. 
 
 
Upon analyzing neat P104 at 28oC, it appears the primary peak, (111) at q0, is suppressed 
with added cisplatin, while preserving the higher order peaks. The higher order peaks are also 
enhanced with added cisplatin, evidenced by a sharp rise in the signal to noise ratio. For 
example, for the fcc peak (220) at (4/3)1/2q0 for neat P104, the intensity increased from 0.13:0.18, 
while with added cisplatin, the intensity for the same peak increased from 0.16:0.26. This 
suggests cisplatin either enhances the structural ordering of the fcc phase of micelle formation in 
P104 or the platinum atom, itself  a strong scatterer, and its colocation in organized arrays within 
the micelles enhances the coherence of the scattering when its partitioned within the colloidal 
crystals. Since the higher order peaks are enhanced and no broad scattering is observed once 
cisplatin is added, it is reasonable to consider that cisplatin is situated within the micelle structure 
and not randomly distributed in solution. This adds further evidence to our previous claim (using 
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DSC) that the moderately hydrophilic cisplatin is found both distributed within the corona and at 
the core-shell interface of the micelle structure [104]. There are also slight shifts to higher q 
values with added cisplatin (Table 3.2), which the presence of cisplatin reduces the lattice plane 
spacing [157]. This observation compares to work we have previously discovered using DLS to 
determine micelle size [16]. We concluded the presence of methylparaben increased the micelle 
monodispersity, which led to tighter packing with fewer defects in the lattice, thus producing 
small observed shifts in the lattice parameter [16]. Further studies are needed to better 
characterize the size of P104, P105, and F108 micelles with added cisplatin. The additives may 
play a role in facilitating transitions between regions within the micelle. 
Not shown here, adding cisplatin had little effect on the temperature where ordering 
occurred relative to neat P104 samples. For example, an ordered phase was first seen in the 20oC 
measurement for neat P104, as compared to 17oC-20oC measurement for the cisplatin mixed 
P104 samples. The breakdown of the neat P104 ordered phases were, however, evident at higher 
temperatures. As shown in Figure 3.1 [157], the fcc phase is present at 28oC, but a breakdown of 
the fcc phase occurs between 30oC -34oC. As the concentration of cisplatin increased, however, 
the presence of ordered phases was preserved at slight higher temperatures (29oC-30oC). This 
indicates a cisplatin induced stabilization of the quasicrystalline lattice in P104 gels at slightly 
higher temperatures. Preserving ordered phases with the addition of a ternary additive was 
previously observed with the addition of methylparaben and dexamethasone in F127 gels [15]. 
Figure 3.2 [157] compares the presence of ordered phases for neat P105 (31% mass v-1) 
and P105 mixed cisplatin (0.1% mass v-1) at 28oC with peak identifications. A full list of peak 
positions and phase structure for neat P105 (31% mass v-1) and cisplatin mixed P105 (0.1% mass 
v-1) at 28oC is listed in Table 3.2 [157].   
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Figure 3.2: Comparison of peak identifications of neat P105 (31% mass v-1) and P105 mixed 
cisplatin (0.1% mass v-1) at 28oC [157]. 
 
In this case, for cisplatin mixed P105 at 28oC, it appears the primary peak, (110) at q0, 
was not suppressed, but only the bcc peak (211) at 31/2q0 was enhanced (increase from 0.16:0.23 
to 0.17:0.26). The bcc peak (200) at 21/2q0 is also more defined with added cisplatin which 
suggests cisplatin enhances the structural ordering of the bcc phases of micelle formation in P105 
and the phases are stable. Since the higher order peaks are enhanced and no random scattering is 
observed once cisplatin is added, this also indicates cisplatin is situated within the micelle 
structure and not randomly distributed in solution. There is a slight shift to lower q values with 
added cisplatin (Table 3.2), which indicates cisplatin is increasing the lattice plane spacing by a 
small amount [157]. 
Similar to P104, the presence of cisplatin had little effect on the temperature where 
ordering occurred relative to neat P105 samples. For example, an ordered phase was first seen in 
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the 18oC measurement for neat P105 as compared to 20oC measurement for the cisplatin mixed 
P105 samples. Breakdown of the ordered phases was also evident at higher temperatures for neat 
P105 as the bcc phase with the highest intensity was at 28oC, with decreasing intensity at 30oC, 
and random scattering at 34oC. For cisplatin mixed P105, however, the highest intensity was 
preserved at 30oC, with random scattering at 34oC. Cisplatin helped to stabilize the 
quasicrystalline lattice in P105 gels as well.  
Figure 3.3 [157] compares the presence of ordered phases for neat F108 (31% mass v-1) 
and F108 mixed cisplatin (0.1% mass v-1) at 28oC with peak identifications. A full list of peak 
positions and phase structure for neat F108 (31% mass v-1) and cisplatin mixed F108 (0.1% mass 
v-1) at 28oC is listed in Table 3.2 [157]. 
Figure 3.3: Comparison of peak identifications of neat F108 (31% mass v-1) and F108 mixed 
cisplatin (0.1% mass v-1) at 28oC [157].  
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Similar to cisplatin mixed P104 at 28oC, cisplatin mixed F108 has the primary peak, 
(110) at q0, suppressed significantly. This primary peak suppression was observed previously 
with dexamethasone and F127 [15] and thin films of poly(alkoxyphenylenevinylene-b-isoprene) 
rod-coil copolymers arranged into lamellar structures [158]. In this case, cisplatin reduces the 
higher order peaks (from 0.17:0.21 to 0.16:0.18), which suggests cisplatin destabilizes the 
structural ordering of the bcc phase of micelle formation in F108. Since the higher order peaks 
are compressed and there is evidence of random scattering observed once cisplatin is added, this 
would suggest cisplatin is not fully situated within the micelle structure and it is randomly 
distributed in solution. This would make sense, since cisplatin is moderately hydrophilic and 
F108 is 80% hydrophilic, so the platinum particles are randomly distributed throughout the 
corona and aqueous solution.  Similar to P105, there are also slight shifts to lower q values with 
added cisplatin for F108 (Table 3.2), which indicates cisplatin is expanding the lattice plane 
spacing [157]. 
Similar to P104 and P105, the presence of cisplatin also had little effect on the 
temperature where ordering occurred relative to the neat F108 samples. An ordered phase was 
first seen in the 22oC measurement for neat F108, as compared to 23oC measurement for the 
cisplatin mixed F108 sample. Breakdown of the ordered phases was evident at higher 
temperatures for neat F108 as the phases with the highest intensity was present at 30oC, and 
random scattering at 34oC. For cisplatin mixed F108, the same trend was observed. This 
indicates cisplatin has no effect on the stabilization of the quasicrystalline lattice in F108 gels.  
 Studies have been carried out to measure the localization or interaction of ternary 
additives with PEO-PPO-PEO micelles [159-163]. Desale et al. [164] used an anionic glutamic 
acid block to coerce cisplatin more comprehensively to the core-shell interphase separating the 
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hydrophilic and hydrophobic blocks to conjugate and alter the cisplatin binding within the 
micelle. Based on prior work [104], we believe that the added cisplatin is also localized in the 
core-shell interphase of the micelles for P104, and P105. The moderate hydrophilicity of 
cisplatin might help explain why the enhanced intensity of structural ordering in P104 and P105, 
but not in F108. There is something about the ratio of hydrophilic to hydrophobic segments for 
P104 and P105 that interacts with cisplatin and affects the energetics. 
Table 3.2 [157] shows the identified peak positions for each sample in Figures 3.1, 3.2, 
and 3.3 [157], and the associated crystal structure identified from peaks present at 28oC. Table 
3.2 [157] also shows the calculated size of each cubic unit cell, 𝑎 (Å), using Equation (3.1), and 
the calculated linear thermal expansion coefficient, αL (oC-1), using Equation (3.6) [157].  
 
Table 3.2: Fundamental (q0) and higher order (qn) peaks (in units of Å
-1), identified phase 
structure, fcc (a), bcc (b), unit cell size, 𝑎 (Å), and linear thermal expansion coefficient, αL (oC-1), 
at 28oC for neat P104, P105, and F108 (31% mass v-1) and mixed cisplatin (0.02% - 0.1% mass 
v-1) [157].  
Sample q0 (Å-1) q1 q2 q3 q4 Phase 𝒂(Å) αL (oC-1) 
Neat P104 .0462 .0541a .0765a .0900a - FCC 232 9.7x10-3 
P104-cisp 0.02% .0463 .0537a .0761a .0891a - FCC 234 8.1x10-3 
P104-cisp 0.04% .0493 .0555a .0785a .0918a - FCC 226 8.6x10-3 
P104-cisp 0.06% .0509 .0535a .0781a .0910a - FCC 227 9.0x10-3 
P104-cisp 0.08% .0492 .0546a .0776a .0909a - FCC 229 9.0x10-3 
P104-cisp 0.1% .0483 .0556a .0787a .0925a - FCC 226 8.8x10-3 
Neat P105 .0478 .0577b .0822b .0962b - BCC 187 3.8x10-3 
P105-cisp 0.1% .0470 .0573b .0813b .0953b - BCC 189 4.4x10-3 
Neat F108 .0410 .0578b .0709b .0820b .0913b BCC 217 1.8x10-4 
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F108-cisp 0.1% .0399 .0565b .0691b .0790b .0890b BCC 223 1.6x10-3 
 
It is interesting to note that the most hydrophobic copolymer, P104, is fcc, while the most 
amphiphilic, P105, and most hydrophilic, F108, is bcc. This may indicate that hydrophilicity 
plays a role in the phase of the micelle structures at these temperatures.  
For P104, the neat copolymer and cisplatin mixed copolymer were all fcc phases with 
identifying peaks (111), (200), (220), and (311) (at q0, (4/3)
1/2q0, (8/3)
1/2q0, (11/3)
1/2q0, 
respectively). Santos et al [140] also reported fcc phase structure in the Fm3m space group for 
30%, 40%, and 34% P104 in 70% H2O, 60% H2O, and 63.4% H2O/2.4% poly(acrylic acid) 
respectively at 25oC. For P105, the neat copolymer and cisplatin mixed copolymer were all bcc 
phases with identifying peaks (110), (200), (211), and (220) (at q0, 2
1/2q0, 3
1/2q0 and 2q0 
respectively). Hossain et al. [145] also reported bcc phase structure in the Im3m space group for 
39% P105 in 61% water at 25oC. Alexandridis et al. [147], however, observed a primitive phase 
structure in the Pm3n crystallographic space group for 40%/60% P105/formamide at 30oC. For 
F108, the neat copolymer and cisplatin mixed copolymer were both bcc phases with identifying 
peaks (110), (200), (211), (220), and (310) (at q0, 2
1/2q0, 3
1/2q0, 2q0, and 5
1/2q0 respectively). 
Quinn et al. [152], however, reported a reversed “double diamond-type” cubic phase, with a 
Pn3m space group for 0.5 g L-1 F108-graphene dispersions at 25oC.    
3.3.2  Unit Cell Size 
Figure 3.4 [157] shows the effect cisplatin concentration has on the unit cell size of P104 
micelles using Equation (3.1) for neat P104 (31% mass v-1) and cisplatin (0.02%-0.1% mass v -1) 
mixed P104 at 28oC. The calculated unit cell size for each sample is listed in Table 3.2. 
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Figure 3.4: Neat P104 (31% mass v-1) and cisplatin (0.02-0.1% mass v-1) mixed P104 unit cell 
determination (q/2π)2 versus (h2 + k2 + l2) from Equation (3.1) [157].  
 
As shown in Figure 3.4 [157] and calculated unit cell size values in Table 3.2 [157], 
cisplatin has a slight effect on the size of the unit cell for P104. As the concentration of cisplatin 
increases, the size of the unit cell decreases. For example, neat P104 has a unit cell size of 232 Å, 
while 0.02%, 0.04%, 0.06%, 0.08%, and 0.1% each have unit cell sizes of 234 Å, 226 Å, 227 Å, 
229 Å, and 226 Å respectively. This suggests that the volume of the unit cell is decreasing with 
increasing cisplatin concentration. This also suggests there is a decrease in water swelling of the 
PEO block. Kayali et al. [136] observed a similar trend of decreasing interfacial area per PEO 
block with increasing copolymer content in P104.  Our neat P104 unit cell size is larger than  
those by Santos et al. [140] who calcuated 207 Å for 30% P104/70% H2O. When Santos et al. 
[140] increased P104 to 36%, and mixed with 54% H2O and 10% poly(acrylic acid)25, they saw a 
more dramatic decrease in unit cell size from 207 Å to 154 Å. 
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Figure 3.5 [157] shows the plot of determining the size of the unit cell using Equation 
(3.1) for neat P105 (31% mass v-1) and cisplatin (0.1% mass v -1) mixed P105 at 28oC. The 
calculated unit cell size for each sample is listed in Table 3.2 [157].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed P105 unit cell 
determination (q/2π)2 versus (h2 + k2 + l2) from Equation (3.1) [157]. 
 
Evidenced by the similar slopes and calculated unit cell size values in Table 3.2 [157], 
cisplatin has no significant effect on the size of the unit cell for P105. Neat P105 has a unit cell 
size of 187 Å, while 0.1% cisplatin mixed P105 slightly increased to 189 Å. The no effect on 
unit cell size with the addition of a ternary additive was previously observed by our group using 
DLS for neat F127 (110 Å) and methylparaben mixed F127 (110 Å) at 90o scattering angle [16]. 
Alexandridis et al. [146] also observed only a slight increase in micelle radius as the volume 
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fraction of P105 was increased at 25oC, but in this case, it was attributed to the increased amount 
of PPO in the system which caused a decrease in the area of the PEO block. 
Figure 3.6 [157] shows the plot of determining the size of the unit cell using Equation (3.1) 
for neat F108 (31% mass v-1) and cisplatin (0.1% mass v -1) mixed F108 at 28oC. The calculated 
unit cell size for each sample is listed in Table 3.2 [157]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6: Neat F108 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed F108 unit cell 
determination (q/2π)2 versus (h2 + k2 + l2) from Equation (3.1) [157]. 
In this case, the addition of cisplatin has a slighly higher effect on the size of the unit cell for 
F108 compared to P105, as shown in Table 3.2 and Figure 3.6 [157]. Neat F108 has a unit cell 
size of 217 Å, while 0.1% cisplatin mixed F108 increased to 223 Å. This suggests that the 
addition of cisplatin causes a slight swelling of the micelle structure. Santos et al. [140] also 
observed an increase in the unit cell size from 207 Å for 30% P104/70 H2O, to 214 Å for 34.1% 
P104/63.4% H2O/2.4% poly(acrylic acid)6000.  
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It is interesting to note that with the addition of cisplatin, the more hydrophobic P104 saw a 
slight decrease in unit cell size, the more amphiphilic P105 saw no change, and the more 
hydrophilic F108 saw a slight increase in unit cell size. This may suggest that hydrophobicity 
plays a role in the size of the unit cell when a slightly hydrophilic ternary additive is introduced.    
3.3.3  d-spacing and Thermal Expansion 
Figure 3.7 [157] shows the length distance, d (Å), between adjacent (hkl) lattice planes 
for the fcc crystal structure of neat P104 (31% mass v-1) and cisplatin (0.02%-0.1% mass v-1) 
mixed P104 with increasing temperature.   
Figure 3.7:  d-spacing (Å) of neat P104 (31% mass v-1) and cisplatin (0.02%-0.1% mass v-1) 
mixed P104 with increasing temperature [157]. 
As shown in Figure 3.7 [157], as the concentration of cisplatin is decreased, the spacing 
between adjacent lattice planes for P104 is decreasing with increasing temperature. For example, 
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the distance per unit temperature for neat P104 is 0.73 Å/oC. The distance per unit temperature 
for decreasing cisplatin concentration is 0.76 Å/oC, 0.72 Å/oC, 0.68 Å/oC, 0.67 Å/oC, and 0.61 
Å/oC for 0.1%, 0.08%, 0.06%, 0.04%, and 0.02% respectively. This suggests that the distance 
between lattice planes for P104 and cisplatin is concentration dependent. This also suggest that 
without the presence of cisplatin, water has a swelling effect of the PEO block causing the 
distance between adjacent lattice planes to decrease. Santos et al. [140] also observed a similar 
trend as the calculated length of 45.3% P104/54.7% H2O was 129 Å, and with the formulation of 
49% P10/31% H2O/20% PAA6000 and 54.4% P104/20.7% H2O/24.9% PAA25, the distance 
decreased to 119 Å and 109 Å respectively.  
 Using the data in Figure 3.7 [157] and Equation (3.6), the linear thermal expansion 
coefficient, αL, was calculated for neat P104 (31% mass v-1) and cisplatin (0.02%-0.1% mass v-1) 
mixed P104. Results are shown in Table 3.2 [157]. As expected, the linear thermal expansion 
coefficient is decreasing as the concentration of cisplatin is decreasing. For example, the 
coefficient at neat P104 is 9.7x10-3 oC-1, while with added cisplatin, the coefficient decreases to 
8.8x10-3 oC-1, 9.0x10-3 oC-1, 9.0x10-3 oC-1, 8.6x10-3, and 8.1x10-3 oC-1, for 0.1%, 0.08%, 0.06%, 
0.04%, and 0.02% cisplatin respectively. This further indicates that water has a swelling effect 
without the presence of cisplatin which decreases the distance between adjacent lattice planes of 
the fcc P104 crystal structure as the temperature is increased.  
Figure 3.8 [157] shows the length distance, d (Å), between adjacent (hkl) lattice planes for 
the bcc crystal structure of neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed P105 
with increasing temperature.   
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Figure 3.8: d-spacing (Å) of neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed P105 
with increasing temperature [157]. 
For P105, it seems cisplatin has the opposite effect compared to P104 for the spacing 
between adjacent lattice planes. As shown in Figure 3.8 [157], the spacing per unit temperature 
in neat P105 is 0.25 Å/oC, while with added cisplatin this length slightly increases to 0.30 Å/oC. 
This suggests that cisplatin has no swelling effect of the PEO block, and overall the structural 
parameter is only slightly influenced by temperature or the addition of cisplatin. Alexandridis et 
al. [146] also reported a slight increase in the lattice paramenters, d (Å), for 60%/40% 
P105/water, but overall the phases are not much influenced by the increase in temperature (from 
20oC to 70oC). Our d-spacing length values for adjacent P105 lattice planes are comparable to 
Hossain et al. [145] that reported between 50 Å and 100 Å for 39:61 P105-water at 25oC. 
Using the data in Figure 3.8 and Equation (3.6) [157], the linear thermal expansion 
coefficient, αL, was calculated for neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed 
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P104. Results are shown in Table 3.2 [157]. As expected, the linear thermal expansion 
coefficient slightly increased with the addition of cisplatin from 3.8x10-3 oC-1 for neat P105, to 
4.4x10-3 oC-1 for cisplatin mixed P105. This further indicates that cisplatin has no swelling effect 
of the PEO block, and the overall structure is slightly influenced by temperature.  
Figure 3.9 [157] shows the length distance, d (Å), between adjacent (hkl) lattice planes 
for the bcc crystal structure of neat F108 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed 
F108 with increasing temperature.   
  
 
Figure 3.9:  d-spacing (Å) of neat P105 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed P105 
with increasing temperature [157]. 
For F108, it seems cisplatin has a profound effect on the spacing between adjacent lattice 
planes in the bcc F108 crystal structure. As shown in Figure 3.9 [157], the spacing per unit 
temperature in neat F108 is 0.012 Å/oC, while with added cisplatin the length significantly 
increased to 0.13 Å/oC. This suggests that cisplatin has no swelling effect of the PEO block, but 
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the presence of cisplatin does cause the distance between adjacent lattice planes to increase. As 
shown in Figure 3.3 [157], cisplatin destabilizes the structural ordering of the bcc phase of 
micelle formation in F108. As the temperature is increased with added cisplatin, there are fewer 
ordered micelle structures in solution which causes the distance between the adjacent crystal 
lattice planes to increase. 
Using the data in Figure 3.9 and Equation (3.6) [157], the linear thermal expansion 
coefficient, αL, was calculated for neat F108 (31% mass v-1) and cisplatin (0.1% mass v-1) mixed 
F108. Results are shown in Table 3.2. As expected, the linear thermal expansion coefficient 
significantly increased with the addition of cisplatin from 1.8x10-4 oC-1 for neat F108, to 1.6x10-3 
oC-1 for cisplatin mixed F108. This further indicates that cisplatin has no swelling effect of the 
PEO block, and the overall structure is greatly influenced by the addition of cisplatin and the 
change of temperature.  
3.4  Conclusions 
SAXS analysis of P104, P105, and F108 solutions also containing cisplatin has revealed 
several key changes in their phase behavior relative to neat systems. For P104 and P105, the 
presence of cisplatin facilitates or enhances the structural ordering with sharper peaks at the same 
temperatures compared to the neat samples. Unexpectedly, F108 showed the opposite effect as 
the intensity decreased with added cisplatin indicating a destabilization of the ordered phases. 
We have found little evidence to suggest that the presence of cisplatin helps coerce ordering of 
P104 and P105 as they evolve, but it apparently adds to the structural disorder in F108, a more 
hydrophilic colloidal crystal. The presence of cisplatin in the amphiphilic copolymers also 
produced a unique scattering behavior compared with the neat samples in that the fundamental 
scattering peak was suppressed for much of the tested temperature range. 
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The presence of cisplatin stabilized the quasicrystalline lattice in P104 and P105 gels, 
evidenced by the preservation of ordered phases and high scattering intensities at 30oC for 
cisplatin mixed copolymers, but much lower scattering intensities at 30oC for neat copolymers. 
For P104, adding cisplatin reduced the lattice plane spacing by a small amount, shown in Table 
3.2 and Figure 3,7 [157], with increasing temperature suggesting crystal expansion. The linear 
thermal expansion coefficient for neat P104 was 9.7x10-3oC-1. Adding cisplatin tended to lower 
the expansion coefficient in the range of 10-20% over the entire composition range of cisplatin, 
as resolved by SAXS. With F108, the expansion of the neat system was increased significantly, 
evidenced by the over 700% increase in linear thermal expansion coefficient from 1.8x10-4 oC-1 
to 1.6x10-3 oC-1. The P105 crystal expanded slightly (16%) with added cisplatin. 
Increasing cisplatin concentration was also found to have a weak decreasing trend in the 
unit cell dimensions of P104. Above 0.04% cisplatin, there was a pronounced 2-3% reduction in 
then unit cell size suggesting that there is larger shell overlap in the presence of cisplatin.  
Cisplatin had no effect on the size of P105 unit cell and F108, cisplatin increased the unit cell 
size as neat F108 217 Å, while 0.1% cisplatin mixed F108 increased to 223 Å. This indicates that 
cisplatin is influencing the overlap of the hydrophilic segments in the unit cell from where its 
situated in the micelle 
These experiments show how using SAXS coupled with a dynamic heating protocol, 
structural changes in P104, P105, and F108 amphiphilic copolymer solutions (31% mass v-1) can 
be characterized when formulated with the ternary additive cisplatin (0.02% to 0.1% mass v-1). 
We have shown here that the evolution of the fcc or bcc phase in PEO-PPO-PEO solutions 
follow a nucleation and growth mechanism over a range of temperatures (10oC to 35oC). We 
have observed that adding cisplatin as a ternary additive alters the evolution mechanism from a 
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homogenous to a heterogeneous nucleation. Understanding where chemotherapeutic molecules 
as ternary additives are partitioned within micelles and how they influence the evolving structure 
is important to optimize controlled release systems utilizing amphiphilic copolymers as a drug 
delivery system.  
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CHAPTER IV 
 
Diffusion and Controlled Release of Colloidal Gels 
 
 
4.1  Introduction 
 
Our group has previously studied the effects a third component has on the driving force 
to form polyethylene oxide-polypropylene oxide-polyethylene oxide, PEO-PPO-PEO, micelles 
linked with thermodynamics [72, 104], structural evolution [15], and its gelation [16]. We have 
observed that the third species helps as a chaperone to coerce the formation of micelles and 
colloidal crystals, at lower temperature than what forms normally in the neat stage [72, 104, 15, 
16].  It is clear that the driving force to form a gel is influenced by the third component and as 
phase separation arises, the amphiphilic qualities of the additive likely have an effect on where 
within the forming micelles the ternary constituent is found [72, 104]. The location of the drugs 
within the micelle can also affect the permeability and bioavailability of drug elements 
sequestered within a forming colloidal gel [72, 104].   
Our goal is to package cold chemotherapeutic drugs in these dispersions below their 
critical micelle temperatures, and inject them via syringe-intratumoral delivery therefore 
bypassing an IV drip. Latent body temperature equilibration will trigger the micelle and gelation 
of the copolymer and drug within, causing the drug to be sequestered and alter the release 
characteristics over time rather than from solution. In this chapter, we ran a series of diffusion 
experiments using dialysis tubing cellulose membrane on aqueous polymeric micelles (Pluronic 
F127) mixed with ternary additives at two temperatures over time to study the release 
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characteristics of micelles using Ultraviolet-Visible spectroscopy (UV-Vis) to monitor the 
release rate. The ternary additives studied here are cisplatin, malachite green chloride (green 
dye), and erythrosin B (red dye).   
The experiments, results, and discussion covered in this chapter were submitted and 
published in the Journal of Surfactants and Detergents [165]. 
4.2  Materials and Methods 
4.2.1  Materials 
Polyethylene oxide-polypropylene oxide-polyethylene oxide, PEO-PPO-PEO, Pluronic 
F127 (12,600 g/mol molecular mass), malachite green chloride (C23H25ClN2, 364.91 g/mol 
molecular mass), erythrosin B dye (C20H8I4O5, 835.89 g/mol molecular weight) and cisplatin 
([Pt(NH3)2Cl2], 300.05 g/mol molecular mass) were all obtained from Sigma-Aldrich 
(Milwaukee, WI) and were used as received. The structures of each are shown in Figure 4.1 
[165]. The dialysis tubing cellulose membrane, also obtained from Sigma-Aldrich (21 mm 
average diameter, 33 mm average flat width, 110 ml/ft capacity, 14,000 g/mol molecular mass 
cut-off), was soaked in room temperature deionized water for 5 minutes prior to use.   
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Figure 4.1: (a) Pluronic® F127 (b) Example of PEO-PPO-PEO micelle structure (c) Malachite 
green chloride (d) Erythrosin B dye (e) Cis-dichlorodiammineplatinum(II) (Cisplatin) [165]. 
 
4.2.2  Kinetics of Ternary Additives Release from Pluronic F127 
Approximately 15cm of dialysis tubing cellulose membrane was measured and placed 
into 500ml of room temperature deionized water for several minutes until the tube opened. Then, 
one end of the tube was sealed with a rubber band seal, while the other end remained open to 
receive the solution. 20ml of each solution was added to each tube by pipette, and then the other 
end of the tube was sealed with a rubber band (leaving space for a small air bubble between the 
liquid and the tied knot). The outside of the tube was rinsed with deionized water. The tube and a 
magnetic stirrer were placed into a 1000ml beaker of 500ml of water (either at room temperature 
or at 40C) on a hot plate. Aliquots of the receiving solution inside the beaker were measured at 
various times using UV-Vis to track the release rate for each ternary additive. A schematic of 
this setup is provided in Figure 4.2 [166].   
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Figure 4.2:  Setup of dialysis tubing experiment (a) at start of dialysis (b) at equilibrium [165]. 
Neat solutions of malachite green (10mg), erythrosin (20mg), and cisplatin (20mg) were 
each mixed into 20ml room temperature water then aliquoted into the dialysis tubing. Aqueous 
solutions of F127 (4g) were each prepared according to the “cold” processing methods of 
Schmolka [29]. The ternary additives were then mixed into each solution containing F127 and 
aliquoted into the dialysis tubing. Total volume of deionized water was maintained by adding the 
same volume of fresh deionized water. Each cumulative release profile (in the form of increasing 
UV intensity vs time) of the ternary additives was calculated from the absorption vs 
concentration plots (calibration curves) for each neat ternary additive. Our cisplatin release 
values are compared to Cheng et al. [64] whom used porous hollow Fe3O4 nanoparticles for 
controlled release of cisplatin. Their cumulative release profile of cisplatin was obtained via the 
concentration correction (the amount of cisplatin in each aliquot calculated to correct the overall 
cumulative releasing of cisplatin) of released cisplatin based on the following equation [64]:  
𝐶𝑡
′ = 𝐶𝑡 +
𝑣
𝑉
∑ 𝐶𝑡
𝑡−1
0
 
(b) (a) 
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Where 𝐶𝑡
′ is the corrected concentration at time t, 𝐶𝑡 is the apparent concentration at time 
t, v is the volume of the aliquots taken and V is the total volume of the solution.  In this study, 
four separate conditions were tested for each ternary additive: neat additive at room temperature 
(20°C-25°C), neat additive at ~40°C (approx. body temperature), F127 mixed additive at room 
temperature (20°C-25°C), and F127 mixed additive at ~40°C (approx. body temperature). Since 
each ternary additive has a different diffusion release rate, UV-Vis measurements were taken 
between 200nm and 850nm at varying times per each condition for more accurate calculations, 
using a Varian Cary 50 Bio UV-Visible Spectrophotometer (Varian Inc. (Agilent Tech.), Palo 
Alto, CA, USA). All UV-Vis measurements for malachite green were analyzed every 10 minutes 
up to 1 hour for each condition. All UV-Vis measurements with erythrosin were analyzed every 
30 minutes up to 3 hours for each condition. UV-Vis measurements involving cisplatin were 
analyzed for several hours throughout several days for each condition. 
 
4.3  Results and Discussion 
4.3.1  Calibration Curves of Ternary Additives 
To study the release kinetics of the encapsulated ternary additives in F127, we dialyzed 
solutions of malachite green, erythrosine, and cisplatin in 500ml deionized water at room 
temperature and 40°C and compared those results to dialysis of dispersions containing the same 
small molecules with F127 in 500ml deionized water at room temperature and 40°C. The amount 
of ternary additive released from the micelle gels was measured by UV-Vis. Calibration curves 
for all three of the neat ternary additives: malachite green, erythrosin, and cisplatin, were 
calculated. Figure 4.3 [165] shows a graphical example of the calibration curve of neat malachite 
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green. In Table 4.1 [165] , we show a summary of our values of each ternary additives’ 
wavelength ranges, concentration ranges (mg/ml), slopes, y-intercepts, and correlation values 
(R2), and compare our results to the cisplatin complex by Basotra et al [167].   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3: Neat malachite green absorption vs concentration calibration curve. Absorption 
analysis were measured in 500ml deionized water using UV-Vis at wavelengths 610-620nm 
[165]. Each measurement was analyzed at 60nm/min for most accurate results. Varian, Inc. 
(Agilent Technologies) reports standard deviation for 10 Abs measurements < 0.00030. 
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Table 4.1: Wavelength ranges, concentration ranges, slopes, y-intercepts, and correlation values 
of malachite green, erythrosin, neat cisplatin, dark colored cisplatin, and cisplatin complex [165]. 
Ternary 
Additive 
Wavelength 
range (nm) 
Concentration 
Ranges 
(mg/mL) 
Slope 
(Abs/conc.) 
Y-
intercept 
(Abs) 
R2 
Malachite 
Green 
610-620 0.004 to 0.02 215 0.1 0.9897 
Erythrosin 520-530 0.008 to 0.04 113 0.5 0.9356 
Neat Cisplatin 270-300 0.02 to 0.22 0.3 0.008 0.9877 
Dark Colored 
Cisplatin 
250-270 0.02 to 0.22 17 1.1 0.9011 
Cisplatin 
Complex 
[167] 
700-710 
[167] 
0.0004 to 
0.0014 [167] 
0.00022 [167] 8.0 x 10-7 
[167] 
0.9999 
[167] 
 
As shown in Figure 4.3 [165], as the concentration of malachite green increases, the 
solution progressed from light green to a darker green tint that absorbed in 610-620nm range. 
This linear relationship was true for erythrosin and cisplatin as well at other wavelengths. For 
erythrosin, as the concentration increases, the solution progressed from light pink to a darker 
pink tint that absorbed in 520-530nm range. Basotra et al. [167] mixed o-Phenylenediamine with 
cisplatin to form a green colored complex with wavelength ranges 700-710nm.  For neat 
cisplatin, since the dissociation of the yellow solid colored cisplatin is a clear liquid, direct visual 
observation is not possible hence the importance of UV-Vis to measure absorbance in the UV 
(270-300nm range).  
The dynamic rise in absorption in the receiver solution was used to calculate the 
concentration of the diffused molecules in solution at a given time. During dialysis, aliquots of 
the solution were measured by UV-Vis to resolve a receiving solution concentration. The 
cumulative release of neat ternary additives and ternary additve-F127 at room temperatures and 
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40°C is shown in Figures 4.4, 4.5, and 4.6 [165]. For cisplatin, unexpectedly during our 
experimentation, observable dark black particles formed both inside the dialysis tubing and 
outside the tubing floating around in the receiver solution. This indicates a reaction is occurring 
and forming dark colored precipitates that eventually settled at the bottom of the beaker. Both the 
neat cisplatin trials and the cisplatin-F127 experiments resulted in precipitation occurring faster 
and more obviously in the dispersion than in the neat solution. These observations suggest 
cisplatin is unstable in solution.  The instability is more pronounced at elevated temperatures and 
encapsulating cisplatin in a polymeric micelle might be ineffective in somehow stabilizing 
cisplatin from its transformation potential. We previously opened an old, stored sample of 
unused cisplatin and noticed similar discoloration.  Upon reviewing the literature, Cubells et al. 
[168] concluded cisplatin is unstable in aqueous solutions and the primary mode of 
decomposition involves displacement of the chloride ligand so increasing the chloride ion 
concentration would likely improve the stability of the drug in aqueous solution [168-171]. We 
performed a calibration curve for the dark colored cisplatin and the results are in Table 4.1 [165]. 
Interestingly, the absorbance was much higher at the same concentrations for the dark colored 
cisplatin compared to the normal yellow colored cisplatin at slightly different wavelength ranges 
(250-270 dark colored compared to 270-300 neat cisplatin) which is indicated in Table 4.1 by 
their different slopes (0.3 neat cisplatin compared to 17.1 dark colored cisplatin). Since the dark 
colored particles were observed throughout the experiment for every condition, the calibration 
curve for dark colored cisplatin was used in Figure 4.6 [165] instead of the calibration curve 
results for neat cisplatin to calculate the concentration of diffused cisplatin in solution at a given 
time.  
 
62 
 
4.3.2  Kinetics of Malachite Green 
To study the release kinetics of the encapsulated malachite green in F127, we dialyzed 
neat malachite green in deionized water at room temperature and 40°C and compared those 
results to the dialyzed malachite green-F127 in deionized water at room temperature and 40°C. 
The amount of malachite green released from the micelle gels was measured by UV-Vis at 
wavelengths 610-620 shown in Figure 4.4 [165].  
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Release of neat malachite green, MG, and malachite green-F127, MG-F127, at room 
temperature, RT, and 40°C over time. Each condition the malachite green released was measured 
in 500ml deionized water by UV-Vis at wavelengths 610-620nm [165]. 
Probably what is most valuable from this type of analysis is the ability to extract a mass 
diffusion coefficient measurement for each condition, the determinations of which is shown in 
Table 4.2 [165]. The thickness of the membrane and the surface area of the dialysis tube are 
needed to perform the calculation.  Clearly mass transfer is easiest (highest diffusion coefficient) 
for the MG-40oC without the amphiphile.  Adding the amphiphile, MG-F127-40oC, cuts the flux 
in half but as time went on later in this experiment, there was a noted rise in the permeation rate.  
Similar release characteristics were observed in the neat MG-RT sample. The most sluggish 
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diffusion occurred when the amphiphiles were added and diffusion commenced at room 
temperature. 
One observable was that none of these experiments achieved a saturation dose over the 
time scale evaluated. Clearly, the driving force for continued permeation existed for all 
experiments and we cannot comment on whether there was a difference in total release.   
The rationale for why elevated temperature led to higher permeation is clear.  There is 
higher Brownian motion in the solution when the temperature is raised from room temperature to 
40oC, and it is possible that the pore dimensions grow making the membrane more permeable 
with higher temperature as well.  The increased activity of the higher temperature solution 
explains why the neat solutions show higher flux and a higher apparent diffusion coefficient at 
higher temperature.  
The presence of the amphiphile has two likely physical outcomes. At elevated 
temperature, there is clearly enough energy to trigger the formation of the colloidal crystals and 
the more the amphiphiles are organized into bulk structures in solution, the lower the probability 
that the surfactants are bound on the wall of the membrane blocking MG transport.  If the 
amphiphiles organize into hydrophobic cores, those regions are effectively excluded volume for 
aqueous soluble MG which will raise the concentration in the water phase and increase the mass 
flux across the boundary. Of course, if MG was strongly bound to regions of the amphiphiles 
because micelles have larger micellar hydrodynamic radii at elevated temperatures, there might 
be a lower driving force for allowing MG to permeate out of the dispersion. Clearly, lower 
transport was not observed. 
Lower temperature lowers the driving force for forming micelles and gels. Our group has 
pointed out that the typical micelle formation temperatures dropped with higher concentrations 
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of F127 and with some ternary additives that interact with the micelle regulating the energetics 
of micelle formation [72, 104, 15, 16].  If the driving force to form micelles is small, it is quite 
possible that more adsorbed surfactant is blocking pores in the membrane. Clearly, the lower 
temperature is also reducing the Brownian motion as well, but here comparing MG-RT and MG-
F127-RT, the presence of the surfactant is a strong impediment to permeation. Considering F127 
reduced the release rate of malachite green at room temperature and 40oC, this suggests it would 
offer a desired platform for drug delivery and release.  
4.3.3  Kinetics of Erythrosin Release 
To study the release kinetics of the encapsulated erythrosin in F127, we dialyzed neat 
erythrosin in deionized water at room temperature and 40°C and compared those results to the 
dialyzed erythrosin-F127 in deionized water at room temperature and 40°C. The amount of 
erythrosin released from the micelle gels was measured by UV-Vis at wavelengths 520-530nm 
shown in Figure 4.5 [165]. 
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Figure 4.5: Release of neat erythrosin, ER, and erythrosin-F127, ER-F127, at room temperature, 
RT, and 40°C over time. Each condition of the erythrosin released was measured in 500ml 
deionized water by UV-Vis at wavelengths 520-530nm [165]. 
The diffusion coefficient measurements for each erythrosin condition is provided in 
Table 2 [165].. Similar to malachite green, the highest flux for erythrosin is ER-40oC without the 
amphiphile. Adding the amphiphile, ER-F127-40oC, cut the flux in half but as time went on in 
the experiment, there was a noted burst in the permeation rate. There was no observable change 
in release characteristics between the neat ER-RT and ER-F127-RT samples as both showed 
very low release (below 10%). 
Similar to malachite green, none of these experiments achieved a saturation dose over the 
time scale evaluated. The driving force for continued permeation existed for all experiments, but 
we cannot comment on whether there was a difference in total release. At 40oC, once again the 
Brownian motion is higher and that explains why the diffusion coefficient for ER-40oC is the 
highest in the neat conditions for the first 150 minutes.  
The presence of the amphiphile at elevated temperature cut the mass transfer rate in half 
for the first 150 minutes. There was enough energy to form colloidal crystals lowering the 
probability that the surfactants were bound on the wall of the membrane blocking the ER 
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transport. If ER was strongly bound to regions of the amphiphiles, there might be a lower driving 
force for allowing ER to permeate out of the dispersion. This was not observed as a diffusion 
coefficient of 1.0 ± 0.01 x 10-6 cm2sec-1 was found in this condition. After 150 minutes, we 
observed a rising release of ER that was not observed with MG making the overall dynamic 
release curve more non-linear. The molecular mass of ER is larger than that of MG, so it takes 
longer for ER molecules to percolate through the gel and the membrane. This is an indication 
that while F127 does have a diffusion rate limiting effect on ternary additives, the rate at which 
the diffusion is limited varies for each ternary additive due to the molecular mass of the ternary 
additives.  According to Mandal [172], translational and rotational motion diffusion coefficients 
can occur in solution simultaneously either in series or parallel. In congested polymeric micellar 
conditions, there is a possibility of self-diffusion (slow process) and mutual or collective 
diffusion (fast process). These conditions are indistinguishable when the small amount of 
supporting electrolytes and buffer solutions are present in the systems [173-177]. With the 
method used here, a diffusion coefficient can be determined, but the non-linearity of the ER 
release suggests its non-Fickian and a different model is more appropriate.        
Lowering the temperature lowers the driving force for forming micelles and gels. If the 
driving force to form micelles is small, it is possible that more adsorbed surfactant is blocking 
the pores in the membrane. The lower temperature also reduces the Brownian motion. In this 
case, for ER-RT and ER-F127-RT, the driving force for diffusing ER is so low at room 
temperature, that similar results were observed with and without the amphiphile. Considering 
F127 still reduced the release rate of ER in both conditions, this is another indication that 
suggests it would offer a desired platform for drug delivery and release.  
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 Conceptually, erythrosin permeation through the dialysis membranes has a similar profile 
to MG.  The hydrophilic erythrosin is concentrated in the aqueous regions and excluded from the 
hydrophobic cores of the micelles which increases the concentration gradient across the dialysis 
membrane once micelles form.  And at elevated temperature, the pores in the membrane are 
larger.   
4.3.4  Kinetics of Cisplatin Release 
The same protocol was used for dialyzed neat cisplatin in deionized water at room 
temperature and 40°C and compared to that of dialyzed cisplatin-F127 in deionized water at 
room temperature and 40°C. The amount of cisplatin released from the micelle gels was 
measured by UV-Vis at wavelengths 250-270nm shown in Figure 4.6 [165]. The cumulative 
release results in general compares well to previous cisplatin encapsulated drug delivery systems 
[64, 30, 178-180]. Guven et al. [30] reported less than 25% total released cisplatin from their 
Pluronic-F108-wrapped, W-CDDP@US-tubes after 200 hours. Cheng et al. [64] reported less 
than 10% total cisplatin release from their Fe-cisplatin loaded nanoparticles, Pt-PHNPs, at pH 
7.4, 6, and 5 after 70 hours. Reardon et al. [178] reported less than 20% cumulative release of 
cisplatin after 10 hours from their core-shell poly(lactic-co-glycolic acid) (PLGA) nanoparticles. 
Fang et al. [179] reported less than 25% total cisplatin release from their chitosan hydrogels after 
5 hours. Czarnobaj and Lukasiak [180] reported less than 50% cisplatin release after 20 hours 
from their silica (SiO2) xerogels at room temperature and 120
oC.  
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Figure 4.6: Release of neat cisplatin and cisplatin-F127 at room temperature, RT, and 40°C over 
time. Each condition of the cisplatin released was measured in 500ml deionized water by UV-
Vis at wavelengths 250-270nm [165]. 
 
The diffusion results were unlike a normal diffusion profile. We observe a burst condition 
for three of the solution conditions including cisplatin neat (cisplatin-RT) in water at 25oC, and 
for both dispersions (cisplatin-F127-RT and cisplatin-F127-40oC)) at ambient temperature and at 
40oC. Reardon et al. [178] and Fang et al. [179] both also observed an initial burst release of 
cisplatin from their core-shell PLGA nanoparticles  and chitosan hydrogels. It is worth noting 
that the size of the initial burst release is on the order of 8-9% while the neat MG and erythrosin 
release substantially more over the 150 hours of experimentation. We calculated a diffusion 
coefficient for the short, initial burst phase, but it is clear that three of the four conditions, there 
is burst followed by a much smaller release, compared with the systematic release of other dye 
molecules.  The diffusion coefficient measurements for each cisplatin condition is provided in 
Table 4.2 [165]. From the analysis, the highest flux observed for cisplatin was cisplatin-F127-
RT. The cisplatin-F127-RT release was slightly higher than cisplatin-RT. 
0
1
2
3
4
5
6
7
8
9
0 50 100 150 200
R
el
ea
se
d
 C
is
p
la
ti
n
 (
%
)
Time (Hours)
Cisplatin-RT
Cisplatin-40°C
Cisplatin-F127-RT
Cisplatin-F127-40°C
69 
 
There was no observable diffusion for neat cisplatin-40oC in the first 5 hours. However, 
cisplatin was observed at much longer times finally permeating through after 50 hours. More 
Brownian motion should occur in the higher temperature neat systems but maybe there is a larger 
driving force to also transform and precipitate neat cisplatin as opposed to driving it across the 
dialysis membrane.  
The presence of the amphiphile at elevated temperature increased the permeation for the 
first 5 hours relative to the neat system. This is possibly due to F127 interacts with cisplatin as 
we observed the formation of dark colored particles floating around in solution. If cisplatin was 
strongly bound to hydrophilic or hydrophobic regions of the amphiphiles, there might be a lower 
driving force to allow cisplatin to permeate out of the dispersion. This was not observed as a 
diffusion coefficient of 1.2 ± 0.1 x 10-6 cm2s-1 was found in this condition. Continued release past 
the burst period is observed and there are indications of a plateau concentration is evident at ~8% 
drug release at longer times. So a little less than half the release comes in the first 5 hours and the 
rest with longer exposure. 
Lowering the temperature lowers the driving force for forming micelles and gels. The 
lower temperature also reduces the Brownian motion. We observed a slightly higher initial burst 
at room temperature for the dispersion (F127-cisplatin RT) relative to the neat solution 
(cisplatin-RT). Since continued release of cisplatin occurred over time even after the initial burst, 
(3% release after 5 hours compared to 8% release after 144 hours), the presence of the 
amphiphile may aid in transporting cisplatin across a membrane.  
Only with the dispersion at elevated temperature (cisplatin-F127-40oC) is a plateau in 
permeation observed. There is a noted decrease in UV-Vis absorption for the other three 
conditions. Clearly, with black particles forming while conducting the diffusion experiments, one 
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rational for the lower absorption later might be due to the sedimentation of converted cisplatin 
particles that are not suspended in solution. If particles are denser than the fluid medium of the 
receiver solution, it’s possible that the particles drift to the bottom of the receiver solution and 
are not sensed as part of the absorption at later time. If there was a nucleation and growth 
mechanism regulating particle formation, if the particles grew in size with time, they might be 
separated in the two-phase dispersion of particles in the receiver reservoir. We observed 
significant particle accumulation at the bottom of the reservoir as well. If the particle formation 
is linked with the inactivation of cisplatin, perhaps doing the experiments in saline solution 
might preserve the activity of the cisplatin and keep it in solution as opposed to directing its 
formation of a second particle phase as a dispersion.   
Comparing the molecular structures of cisplatin with MG and ER, the two dyes are both 
stable and hydrophilic, while cisplatin is clearly unstable and perhaps more ambiguous in terms 
of its overall hydrophilicity.  If the same mechanism of liberating the pores occurs with the 
amphiphile coalescence and formation of hydrophobic cores, if cisplatin was more drawn to the 
interface between the core and shell, that would reduce the amount available at the membrane 
boundary. With a time dependent stability issue, even if cisplatin was labile outside of the cores 
within the dialysis membrane, the fact that there is a nucleation and growth of the dark 
particulates which quickly grew larger than the pore dimensions of the membrane.   
4.3.5  Comparison to Other Permeation Experiments 
Table 4.2 [165] presents our results and includes a comparison of cisplatin diffusion 
coefficient values in a variety of delivery systems. The table includes references for cisplatin 
released from PLGA nanoparticles [178], PLGA microspheres, solid fibers, and hollow fibers 
[181], and chitosan-alginate nanoparticles [182]. 
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Table 4.2: Diffusion coefficient of each experimental condition: neat malachite green, MG, 
erythrosin, ER, and cisplatin (first 5 hours) and mixed F127 at room temperature, RT, and 40oC 
[165]. Our results are compared to the in vitro release of cisplatin from core-shell poly(lactide-
co-glycolide) (PLGA) nanoparticles [178], PLGA microspheres, solid fibers, and hollow fibers 
[181], and electrostatically cross-linked chitosan-alginate nanoparticles [182]. 
Experimental Condition Diffusion Coefficient (cm2s-1) 
MG-RT 2.6 ± 0.01 x 10-7 
MG-F127-RT 2.6 ± 0.01 x 10-8 
MG-40oC 7.9 ± 0.1 x 10-7 
MG-F127-40oC 5.2 ± 0.01 x 10-7 
ER-RT 4.7 ± 0.01 x 10-8 
ER-F127-RT 3.7 ± 0.1 x 10-9 
ER-40oC 5.2 ± 0.01 x 10-7 
ER-F127-40oC 1.0 ± 0.01 x 10-6 
Cisplatin-RT (5 hours) 6.7 ± 0.01 x 10-6 
Cisplatin-F127-RT (5 hours) 3.0 ± 0.1x 10-7 
Cisplatin-40oC (5 hours) 0 
Cisplatin-F127-40oC (5 hours) 1.2 ± 0.1 x 10-6 
Cisplatin-PLGA nanoparticles (150 hours) 4.1 x 10-17 [178] 
Cisplatin-PLGA microspheres (500 hours) 4.8 x 10-13 [181] 
Cisplatin-PLGA solid fibers (200 hours) 6.1 x 10-10 [181] 
Cisplatin-PLGA hollow fibers (400 hours) 3.3 x 10-10 [181] 
Cisplatin-chitosan-alginate nanoparticles (t < 2 hours) 8.2 x 10-1 (average) [182] 
 
Our diffusion results are higher than Campbell et al. [181] who observed much slower 
cisplatin diffusivity from PLGA microspheres. Campbell’s lower diffusivity of cisplatin was 
caused by the low molecular mobility of the matrices where cisplatin is encapsulated. Campbell 
et al. [181] reported some microspheres engulfed other microspheres with shell-like pores 
surrounding some regions of a microsphere causing droplets of oil phase to disperse in the 
aqueous phase. The low porosity of these microspheres suggests more sluggish drug 
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permeability as there are few aqueous channels to allow paths for drug escape [181]. Campbell 
also observed a cumulative drug release over 500 hours, while our reported diffusion coefficient 
numbers are within the first 5 hours of release. 
Our diffusion results are also higher than Campbell et al. [181] for diffused cisplatin from 
PLGA solid and hollow fibers. Campbell reported during fiber drying, as more solvent is 
extracted during the phase inversion, the oil phase becomes a poorer solvent to the polymer 
chains, and the chains retract and interact more with each other causing the glass transition 
temperature, Tg, to increase [181]. Since the polymer chains are less mobile, the diffusivity of 
the solvent in the oil phase decreases thus reduces the volume of the core, causing lower drug 
release [181]. Campbell also observed a cumulative drug release over 200 hours for solid fibers, 
and 400 hours for hollow fibers [181]. 
Our diffusion coefficients appear quite low, relative to Maan et al. [182] for in vitro 
release of cisplatin from electrostatically cross-linked chitosan-alginate nanoparticles. This 
discrepancy could be due to the differences in our controlled drug release methods. Our 
polymeric micelles form gels at elevated temperatures, which encapsulates cisplatin, thus 
significantly reduces its permeation. Maan et al’s [182] release of the cisplatin complex from the 
nanoparticles involves the absorption of water into the nanoparticles matrix and simultaneous 
release of the drug via diffusion. When Maan’s drug encapsulated nanoparticles are exposed to 
water, the polymer swells causing the Tg of the polymer to drop relative to the experimental 
temperature [182]. The release of the drug is regulated by the process of relaxation of 
macromolecular chains and the diffusion of the entrapped drug molecules into the exterior 
medium [182]. The Maan effort was tied to diffusion on a molecular level and our membrane 
dimensions are on the order of 100 microns, much larger overall. Man et al. [182] also observed 
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a cumulative drug release within 2 hours, while our reported diffusion coefficient numbers are 
within the first 5 hours of release. 
Our diffusion results are also very low compared to Reardon et al. [178] for cisplatin 
release from core-shell PLGA nanoparticles. This discrepancy could be due to Reardon et al. 
[178] observed their cumulative release over 150 hours compared to our calculations after 5 
hours. The Reardon effort also fabricated a drug delivery system on the Nano scale while our 
system is on the micro scale. Reardon et al. [178] also observed their diffusion study in 
Phosphate-buffered saline (PBS) while our study was observed in deionized water.  
 
4.4  Conclusions 
In summary, we demonstrated an approach using amphiphilic polymeric micelles (F127) 
to regulate controlled release of two indicator dyes (malachite green and erythrosin) and one 
chemotherapeutic drug (cisplatin). We tested the release at temperatures that would alter the 
driving force for forming colloidal gels in vivo (room temperature and 40oC). We show the 
process tracking dye or drug collection in a receiver solution through a dialysis membrane from 
the absorbance measurements, via UV-Vis, to the determination of an apparent diffusion 
coefficient where applicable. Our cisplatin results were compared to a number of other studies in 
which permeation in a sequestered nanostructure was evaluated for its fluence [181, 182]. 
Adding the amphiphile lowered the permeability of dye molecules (2.6 ± 0.01 x 10-7 cm2s-1 MG-
RT compared to 2.6 ± 0.01 x 10-8 cm2s-1 MG-F127-RT), but tended to result in a burst delivery 
with cisplatin (6% total release with cisplatin-F127-RT compared to 4% total release cisplatin-
RT). We noted instability with cisplatin in aqueous solution [168-171].  
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CHAPTER V 
 
Micelle Gels as Fire Retardants 
 
 
5.1  Introduction 
 
While Chapters II, III, and IV focused on PEO-PPO-PEO micelles for drug delivery 
applications, this chapter explores a novel concept of using micelle gels for fire retardant 
applications.  
Fire is a useful tool throughout human history, but it can bring disasters if not carefully 
controlled [183]. By inhibiting a voluminous fire, there is a better chance for fire-fighters to 
extinguish it or for people to escape uncontrolled fires before they cause significant damage. 
Cotton is a very important natural textile fiber used to produce clothing, furniture, and industrial 
products, but it has a low limiting oxygen index (18%) [184] and thermal decomposition 
temperature (360 °C to 425 °C) that makes it very flammable [185]. When cotton fabrics are 
ignited, the flame spreads rapidly potentially causing fatal burns within 15 seconds of ignition 
[186]. Various methods have been used to impart flame retardancy to cotton fabrics [187-192]. 
Boron and halogenated containing additives have been widely used that function by liberating 
large volumes of non-flammable gases to starve the flames and forming a glass coating, 
respectively, during thermal decomposition [186, 193]. Boron-based flame retardants are quite 
water soluble and might impart only fleeting flame retardancy on fabrics that undergo numerous 
washing cycles [185].  The effectiveness of the most common halogenated flame retardants in 
general has been compromised by their latent toxicity concerns linked with bioaccumulation and 
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exposure issues to both humans and aquatic species in the environment [194]. While there are 
certainly new halogenated chemistries that might prove somehow better than those compounds 
with documented concerns, our focus here is phosphorus-based flame retardants that have also 
been successful in imparting flame retardancy to cellulosic fabrics [195, 196]. Some 
Phosphorous-based coatings can withstand repeated wash cycles [185], reduce volatile fuel, 
lower pyrolysis temperature, increase carbonaceous char, and decrease afterglow [195]. Leistner 
et al. [196] studied the use of chitosan/melamine polyphosphate as a water-insoluble coating on 
cotton fabric via layer-by-layer assembly.  
Layer-by-layer (LbL) deposition [197-201] is a common technique for fabricating 
thinner, multifunctional flame-retardant films/coatings. These coatings are formed by repeatedly 
depositing alternating layers of oppositely charged materials. The multilayer assembly of the 
coating is self-regulated by electrostatic repulsion within the individual layers and is enabled by 
attractive forces; electrostatic [202], van der Waals [203, 204], and H bonding [205, 206]. LbL 
coatings/films can be applied by either dip coating [207, 208] or spray coating [209, 210]. They 
have range of functionalities that can produce conducting films [211-213], antireflection films 
[214, 215], and oxygen barriers [216, 217]. More recently, researchers have pivoted from layer-
by-layer assembly and are aiming for one-step processes for fabricating a flame retardant coating 
on fabrics [218] and polyurethane foams [219]. Each additional monolayer requires an additional 
depositing and washing step; therefore, these 20 or more monolayer coatings required a total of 
30 or more steps in the fabrication process, considerably more than required for the conventional 
and preferred single bath coatings. In this study we propose using melamine, sodium 
hexametaphosphate (SHMP), and polyethylene oxide-polypropylene oxide-polyethylene oxide, 
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PEO-PPO-PEO, triblock copolymer to form a water-insoluble flame retardant gel that can be 
applied onto cotton fabrics. 
Sodium hexametaphosphate (SHMP) [220], melamine [221], and PEO-PPO-PEO triblock 
copolymers are all relatively non-toxic chemicals in small doses. SHMP is used as a sequestrant 
and as a food additive [222]. Melamine is the starting material for resins used in the production 
of a wide variety of thermosetting plastics [223]. When melamine is mixed with SHMP in 
aqueous solution, they form the water-insoluble flame retardant melamine polyphosphate (MPP) 
[196]. The amphiphilic PEO-PPO-PEO triblock copolymer F127 has surfactant properties that 
make it useful in industrial applications including drug delivery [224, 225].           
  Researchers have studied the mechanism for the gel formation of aqueous dispersions of 
PEO-PPO-PEO triblock copolymers and have attributed the gel formation to the close packing 
and ordering of micelles [6, 8, 226]. The PEO-PPO-PEO triblock copolymer F127 (70% PEO 
content) has been studied extensively as it has the most pronounced gel forming abilities of the 
commercially available polymer surfactants [29]. As the temperature of these solutions is 
increased, the decreasing aqueous solubility of the PPO causes micelle formation with the 
hydrophobic (PPO) cores and hydrophilic (PEO) shells [15]. Lam et al [17] suggested that the 
micelles grow via Ostwald ripening and Barba et al [18] suggested that the volume fraction 
occupied by the micelles in solution rises with increasing temperature. The micelles experience 
repulsive interactions and order into quasicrystalline cubic lattices [15]. The observed lattice 
structure for F127 gels are typically face centered cubic or body centered cubic [227, 228]. This 
lattice structure is believed to give these materials their gel-like properties [15].  
This chapter describes chemical formulations and one-step procedures to yield relatively 
non-toxic, flame retardant coatings for cotton fabrics. The coatings were made with the 
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amphiphilic PEO-PPO-PEO triblock copolymer F127, melamine, and SHMP. The impact of the 
formulations on flammability was determined by measuring ignition resistance combustion heat 
released rate, and decomposition behavior using vertical flame testing (VFT), micro-scale 
combustion calorimetry (MCC), and thermogravimetric analysis (TGA). Scanning electron 
microscopy (SEM) was used to observe surface quality assessments of the coatings on the cotton 
fabrics.  
The experiments, results, and discussion covered in this chapter were conducted at the 
National Institute of Standards and Technology (NIST) as a part of the National Physical Science 
Consortium (NPSC) fellowship. This work was submitted to Advanced Materials Interfaces for 
review [23]. 
 
5.2  Materials and Methods 
 
5.2.1  Materials 
Polyethylene oxide-polypropylene oxide-polyethylene oxide, PEO-PPO-PEO F127 
(12,600 g/mol molecular mass), SHMP (Na6P6O18, 611.77 g/mol molecular mass), and melamine 
(C3H6N6, 126.12 g/mol molecular mass) were all obtained from Sigma-Aldrich (Milwaukee, WI) 
and were used as received. The structures of each are shown in Figure 5.1 [23]. The cotton fabric 
(James Thompson & Co. Inc., 228.6 cm Quilter’s Flannel, double-napped 100% cotton) with 
area density of 102g/m2 was used as received. All solutions were prepared using deionized water 
from a PURELAB Flex (18.2 MΩ·cm, ELGA). 
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Figure 5.1: (a) Pluronic F127 (b) sodium hexametaphosphate (c) melamine [23]. 
 
 
5.2.2  Coating Procedure 
Aqueous solutions of F127 were each prepared according to “cold” processing methods 
[29] and formulated in varying concentrations (10% to 20%) to probe its flame retardant 
properties. Concentrations of melamine (5% to 15%) were mixed in aqueous solutions of F127. 
Lastly, varying concentrations of SHMP (5% to15%) were added. The total volume of the 
mixtures during treatment was held constant as an attempt to control the thickness of the 
coatings. After several hours of mixing at room temperature, the coating gel formed. The white 
gel was coated onto the cotton fabric (10 cm by 10 cm) using a stainless steel laboratory spatula. 
Both sides of the cotton fabrics were coated to ensure a thorough coating. The coated cotton 
fabric was placed in an oven for at least 12 hours at 70oC. If the fabric still felt damp to the touch 
after 12 hours, it was placed back in the oven until moisture was no longer present. Two types of 
coating protocols were followed, one with melamine, SHMP, and F127, and the other without 
F127. The protocol without F127 used aqueous solutions of melamine (5%) and SHMP (5%) all 
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mixed into a single bath. The cotton fabric was manually dipped into the solution and soaked for 
10 minutes to allow complete wetting and good adhesion of the coating to the substrate. The 
coated cotton fabric was then placed in an oven at 70°C for a minimum of 12 hours. The 
resulting color of the cotton fabric turned white due to the melamine polyphosphate. The overall 
hand of the fabric after coating felt stiffer and heavier compared to the soft and stretchy feel prior 
to coating. 
 
5.2.3  Flammability Testing 
Ignition resistance assessments were done on the coated fabric using vertical flame 
testing (VFT) to identify promising formulations. These formulations were reproduced and their 
combustion behavior was measured using micro-scale combustion calorimetry (MCC) from 
100°C to 750 °C under an environment of 20% oxygen and 80% nitrogen with a heating rate of 
1°C s-1 and a sample mass of 5mg; using a ASTM D7309 (Concept Equipment). This test 
revealed the influence of the coating on the fabric’s heat release. Thermogravimetric analysis 
(TGA) was also performed on coated fabrics tested from 90°C to 850°C under nitrogen with a 
constant heating rate of 20°C min-1 and a sample mass of 10 mg, using a NETZSCH STA 449 F1 
(Germany). TGA tests revealed the mass loss of the coated sample due to non-oxidative thermal 
decomposition. A Ziess Ultra 60 Field Emission-Scanning Electron Microscope (FE-SEM, Carl 
Zeiss Inc., Thornwood, NY) was used to acquire surface images of the coatings on the cotton 
fabrics under a 5 kV accelerating voltage. All SEM images were sputter-coated with 8 nm of 
gold/platinum (60%/40% by mass) prior to imaging.  
 The cotton fabrics were used as received. No conditioning was performed prior to testing. 
The vertical flame test was setup as shown in Figure 5.2 [23]. The ignition source was applied to 
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the middle, bottom edge of the sample for 5 seconds. If the sample failed to ignite or it self-
extinguished, the torch was applied again at the same place on the fabric for another 5 seconds. 
This ignition process was repeated no more than three times on the same specimen. The test was 
complete when there were no visible flames or when the specimen was completely consumed 
during combustion. The 100% cotton fabric was used as a control to qualitatively rank the 
formulations. The type of behavior used for ranking included the following: number of 
applications of the torch before ignition, time until flames extinguished, and extent of flame 
propagation across the cotton surface. The results of this test is shown in Table 5.1 [23]. 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2: Example of vertical flame test (VFT) setup [23]. 
 
 
 
5.3  Results and Discussion 
5.3.1  Fabrication and Flammability Screening 
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In a single step coating process, PEO-PPO-PEO F127 (F127), co-formulated with 
melamine, and sodium hexametaphosphate (SHMP) flame retardant were deposited as gel 
coatings on cotton fabrics. The coatings were characterized to determine coating morphology 
(SEM) and ignition resistance (vertical flame testing). Only the coatings that did not ignite were 
evaluated through MCC, TGA, and SEM.  
10 flame retardant-coated cotton fabric were made by applying gel coatings containing 
F127 (0%, 15%, and 20%), melamine (0%, 5%, 10%, and 15%), and SHMP (0%, 5%, 10%, 
15%).  The coating composition, mass gain percent (percentage of mass increase after coating is 
applied), and flammability results are provided below in Table 5.1 [23]. The data in Table 5.1 
[23] reflect the averages of at least three specimens for each formulation. 
Table 5.1: Coating composition, mass gain %, and open flame screening for flame retardant-
coated cotton fabrics.  Mass gain is reported with a 2σ uncertainty [23]. 
Coating Composition (%) 
Mass Gain (%) Flammability observations 
F127 Melamine SHMP 
25 10 10 143  10 Ignition, slow flame spread 
 
20 15 15 238  10 No ignition 
 
20 15 - 143  10 Ignition, slow flame spread 
 
20 - 15 137  10 Ignition, charred 
 
20 - - 105  10 Complete combustion 
 
15 15 15 220  10 No ignition 
 
- 5 5 54  10 No ignition 
 
- 5 - 30  10 Extensive combustion 
 
- - 5 10  10 Ignition, charred 
 
- - - - Complete combustion 
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Flammability of a material is defined by a number of factors, including its ignition 
resistance and by the size of the exotherm formed during combustion. Typically for fabrics, 
ignition resistance is the more important of the two, at least for screening fabrics for a specific 
use. Therefore, in this study, ignition resistance tests were used as initial screens of fabric 
flammability.  
Based on the ignition resistance test results from Table 5.1 [23], all the flame retardant 
formulations for cotton raised its flame resistance. The control and 20% F127 gel coated cotton 
fabrics ignited as soon as the ignition flame source was applied. Within 60 seconds the fabrics 
were completely engulfed in flames. The best performing coatings (no ignition, Table 5.1 [23]) 
were the 5% melamine/5% SHMP, 20% F127/15% melamine/15% SHMP, and 15% F127/15% 
melamine/15% SHMP formulations. Depending on the coating on the cotton fabrics, the overall 
mass gain is dramatically affected. Even though the 20% F127/15% melamine/ 15% SHMP 
coating also did not ignite according to Table 5.1 [23], only the 15% F127/15% melamine/ 15% 
SHMP coating was further explored for testing because of its lower coating weight and higher 
ignition resistance. The lower overall mass gain also attributed to a more flexible and softer 
fabric compared to the higher mass gains. A 10% F127/15% melamine/15% SHMP coating was 
also tried, but a gel did not form a coating because it was below the critical gel formation 
concentration [29]. In this case, adding melamine and SHMP was not a strong enough driving 
force to form a gel at 10% F127. In order to compare the combustion behavior and 
decomposition of the paste itself before applying it onto cotton fabrics to the coated fabrics, a 
20% F127/15% melamine/15% SHMP paste was also analyzed using MCC and TGA. 
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5.3.2  Instrumentation: TGA, MCC, and SEM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3: TGA data for F127/melamine/SHMP gel coating on cotton fabric (blue dots), 
melamine/SHMP (red solid line), uncoated cotton fabric (black dash-dots), and coating paste 
itself without cotton fabric (green dashes) [23]. 
 
Table 5.2: TGA properties of uncoated cotton fabric, melamine/SHMP on cotton, 
F127/melamine/SHMP gel coating on cotton, and F127/melamine/SHMP coating paste itself. 
Data is reported with a 2σ uncertainty.  The slopes correspond to the dehydration of the coated 
fabric (1) followed by the active combustion of the dehydrated composite (2) [23].  
Sample ID 1st Slope  
(%/oC) (R2) 
2nd Slope  
(%/oC) (R2) 
Intermediate Plateau 
Temperature Range (oC) 
Residue (%) 
Cotton Control -0.07  
(0.86) 
-0.5  
(0.95) 
 
- 5 ± 1 
5% Melamine 
5% SHMP 
-0.05  
(0.97) 
-0.3  
(0.94) 
 
275-375 20 ± 2 
15% F127 
15% Melamine 
15% SHMP 
-0.08  
(0.99) 
-0.5 
(0.97) 
 
 
300-375 10 ± 2 
20% F127 
15% Melamine 
15% SHMP  paste 
-0.04  
(0.93) 
-0.6  
(0.97) 
325-425 15 ± 2 
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As shown in Figure 5.3 and Table 5.2 [23], TGA results on untreated cotton show some 
level of mass loss below 225oC, but there is a rapid decline in residual mass with rising 
temperature above 225oC. The lower and higher temperature decompositions can be interpreted 
as a two-stage decomposition process with slopes of percent mass loss/oC summarized in Table 
5.2 [23]. Coating cotton with the SHMP/melamine mixtures led to TGA results that show some 
intermediate plateau of mass stability with increasing temperature that makes coated cotton 
degradation more complicated than simply interpreting the two-step degradation model. The 
mass loss at lower temperatures for the coated fabrics is due to the decomposition of melamine 
and SHMP. Both the coating and the cotton contribute to the mass loss of the coated fabrics. 
Despite the 15% F127/15% melamine/15% SHMP coating losing mass at lower temperatures 
than the cotton control, the mass above 400oC for cotton is less than 5% while that for the coated 
cotton is about 15% or less.   
The 5% melamine/5% SHMP, 15% F127/15% melamine/15% SHMP coated cotton, and 
the 20% F127/15% melamine/15% SHMP coating exhibited similar TGA profiles, except the 
coatings had higher mass residues at the end of the test compared to cotton. For neat cotton 
decomposition ended at ~375 °C with 5% 1% of the original mass as char residue.  
Significant mass changes in the TGA residue occurred when the cotton fabric was coated 
with 15% F127/15% melamine/15% SHMP and 5% melamine/5% SHMP. The temperature of 
the onset of degradation occurred at 150oC and 185oC respectively for 15% F127/15% 
melamine/15% SHMP and 5% melamine/5% SHMP, compared to 75oC for cotton control. In 
addition, the char yield increased from 5%  1% for cotton control at 375°C to 10%  2% 
(~100% increase) at 450°C for 15% F127/15% melamine/15% SHMP coating. Since the percent 
mass loss for 20% F127/15% melamine/15% SHMP paste is lower than the percent mass loss for 
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cotton control, the coating is more thermally stable than cotton. Since the 15% F127/15% 
melamine/15% SHMP coating on cotton fabric has a lower percent mass loss than the cotton 
control, this coating on cotton lowers decomposition behavior. The mass loss behavior for 15% 
F127/15% melamine/15% SHMP is similar to that for flame-retardant agent CFR-201 (an 
organophosphorus nitrogen containing compound) reported by Zhu et al [229].  
MCC probed the combustion behavior of the same formulations analyzed by TGA. 
Figure 5.4 [23] shows the heat release rate (HRR) of coated and uncoated cotton with 
temperature (°C). The MCC results are shown in Figure 5.4 and Table 5.3 [23]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: MCC results of F127/melamine/SHMP gel coating on cotton fabric (blue dots), 
melamine/SHMP (red solid line), uncoated cotton fabric (black dash-dots), and coating paste 
itself without cotton fabric (green dashes) [23]. 
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Table 5.3: Heat release properties of uncoated cotton fabric, melamine/SHMP on cotton, 
F127/melamine/SHMP gel coating on cotton, and F127/melamine/SHMP coating paste itself. 
Data is reported with a 2σ uncertainty [23]. 
Sample ID Residue (%) 
(% increased) 
THR (kJ/g) 
(% reduction) 
PHRR (W/g) 
(% reduction) 
Cotton Control 
 
12  1 11  3 183  3 
5% Melamine 
5% SHMP 
39  1 
(218  1) 
 
4  2 
(62  2) 
70  2 
(62  2) 
15% F127 
15% Melamine 
15% SHMP 
30  1 
(144  1) 
 
 
8  12 
(21  12) 
74  12 
(60  12) 
20% F127 
15% Melamine 
15% SHMP paste 
24  1 8  4 133  4 
 
As shown in Figure 5.4 and Table 5.3 [23], 5% melamine/5% SHMP, 15% F127/15% 
melamine/15% SHMP, and 20% F127/15% melamine/15% SHMP paste all show lower heat 
release rates, THR, and PHRR and higher residue mass values than the cotton control. For 
cotton, thermal decomposition initiated at ~ 300°C. The decomposition, as indicated by rising 
HRR, intensified as the temperature rose. The maximum HRR at ~400oC was 183  3 W/g 
which was identified as the peak heat release rate (PHRR). The decomposition was complete at 
550°C with 12%  1 of the original mass as char residue.  
As a percentage basis, the drop-off in PHRR is more dramatic by coating (reductions as 
much as 2/3 of PHRR cotton) whereas the total heat release was only 20-50% lower overall with 
the same coating conditions.  The released energy measurements compare favorably with other 
MCC type measurements on other cotton coatings shown in Figure 5.6 [218, 192].  
As shown in Figure 5.4 [23], the HRR curve for cotton control has one peak, but cotton-
coated fabrics have two peaks. The additional peaks appear at the early stages (lower 
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temperatures) of cotton’s decomposition as shown in Figure 5.4 [23], are due to the 
decomposition of melamine and SHMP. Such premature decomposition of a flame retardant 
would reduce its effectiveness on the coated cotton fabric, therefore identifying ever more 
effective flame retardants packaged within a gel deserves to be probed more.    
SEM images observed the coating quality (surface morphology) of the coated samples. 
SEM images for 15% F127/15% melamine/15% SHMP, 5% melamine/5% SHMP, and cotton 
control are provided in Figure 5.5 [23]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5: SEM images (a) cotton control (b) 15% F127/15% melamine/15% SHMP on cotton 
fabric (c) 5% melamine/5% SHMP on cotton fabric. The 5% melamine/5% SHMP coating is not 
very uniform on the cotton fibers and is randomly dispersed. The 15% F127/15% melamine/15% 
(a) (b) 
(c) 
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SHMP coating shows a more uniform coating on the cotton fibers but there are noticeable cracks 
which indicates insufficient adhesion of the paste onto the cotton fabric [23]. 
 
Some coating was observed on the 5% melamine/5% SHMP, but the coating is randomly 
dispersed as some fibers have more coating on them than others. For the 15% F127/15% 
melamine/15% SHMP coating on cotton fabric, it shows a more uniform mixture of coating 
paste all over the cotton fibers. All of the fibers are coated and completely covered. There are 
some noticeable cracks that appear in the image that indicate insufficient adhesion of the paste 
onto the cotton fabric and varying thickness. A more uniform and thinner coating is required to 
ensure the flame does not touch the fabric directly without dramatically adding to the cotton 
mass. If the flame was more effectively isolated from the flame, the coating will contact the 
flame, causing no ignition. This was a proof in concept and more work is needed to explore a 
more uniform coating thickness, as well as a more stable coating after washing.     
5.3.3  Comparison to Other Technologies 
Figure 5.6 [23] presents other flame retardant strategies, incorporated in or applied onto 
cotton fabrics [192, 196, 218]. These flame retardants were deposited using single bath and LbL 
assembly protocol and constructed using N-methylol dimethylphosphonopropionamide (MDPA) 
and trimethylol melamine (TMM) [192], soaked in a polyethylenimine (PEI)/poly(phosphate 
sodium salt) (PSP) complex [218], polyallylamine/poly(phosphate sodium salt) (PAAm/PSP) 
[218], and PA/CH at PH 4 [218]. The LbL coatings ranged from 10 monolayers to 64 
monolayers and resulted in a mass increase of 2% to 18%.  These deposited coatings gave heat 
release reductions of 42% to 61% (PHRR) and 54% to 76% (THR).   
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Figure 5.6: Comparison of MCC data for F127, melamine, and SHMP coatings to the previously 
reported single bath [218], LbL [218], and MDPA/TMM [192] coatings on or deposits within cotton 
fabrics. Mass gain % (blue), residue % (orange), THR (kJ/g) % reduction (grey), and PHRR 
(W/g) % reduction (yellow) for each recipe is compared. Data is reported with a 2σ uncertainty 
[23]. 
All coatings reduce the cotton flammability by MCC. In terms of total energy of 
combustion, the gel-coating has statistically lower energy released relative to any of the other 
coatings.  That enhancement comes at the cost of a huge increase in coating thickness, primarily 
consisting of amphiphilic copolymer.  The amphiphile is still hydrophilic even after the drying 
process before combustion and its presence probably absorbs energy from the combustion that 
can explain why the THR for the gel coating is so much lower.  Of course, if one could optimize 
the coating thickness to not triple the mass of the fabric, the effectiveness of the coating might be 
diminished.  That same effect could have occurred if the amphiphiles were extracted from the gel 
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coating with subsequent washings.  In terms of a peak combustion rate, there is little difference 
between the coatings and the coating with the lowest PHR is the MDPA/TMM co-mixture which 
is statistically lower than the rest. It is also interesting to note that the presence of more LbL 
layers adds to the mass but doesn't improve the residue or the energy of combustion suggesting 
that the thinnest LbL coatings are more retardant.  
5.4  Conclusions 
Aqueous-based amphiphile solutions have been co-formulated with potentially alternative 
flame retardants in a one-step process to make flame retardant gel coatings for cotton fabrics. 
Coatings containing an amphiphilic block copolymer in aqueous solution and formulated with 
melamine and SHMP on cotton fabrics are self-extinguishing as found by vertical flame testing. 
Coatings with higher compositions of the amphiphile led to lower ignition resistance hence the 
15% F127 composition was used throughout for the subsequent analyses. Coating effectiveness 
was probed with micro-scale combustion calorimetry (MCC) and thermogravimetric analysis 
(TGA). The most successful performing gel formulation was 15% F127/15% melamine/15% 
SHMP which produced 74 W/g 12 W/g in PHRR (a 60% reduction), and 8.0 kJ/g 12 kJ/g in 
THR (a 21% reduction).  The gel coatings are too thick to be commercially viable. The coated 
fabric also turned white due to the melamine polyphosphate. The overall hand of the fabric after 
coating felt stiffer and heavier compared to the soft and stretchy feel prior to coating. SEM 
imaging showed a more uniform coating over all of the cotton fibers for the 15% F127/15% 
melamine/15% SHMP coating compared to less concentrated coatings. The thicker gel coating 
showed evidence of cracks but that alone could have been a function of the large coating film 
thickness. Overall, the scheme for using precursors that result in the formation of a solid phase, 
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insoluble flame retardant in a coating seems valid, although larger amounts of qualification 
testing and better tools to provide for a thinner and more controlled thickness are appropriate.  
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CHAPTER VI 
 
Summary and Future Work 
 
6.1  Summary 
 The aim of this dissertation work was to better understand how ternary additives perturb 
the micelle formation energetics and where within the micelle ternary additives are portioned to 
resolve how formulated micelles perform as drug delivery vehicles. We attempted to better 
understand the linkage between forming structures of amphiphiles housing other molecules and 
the effect on availability and performance. Chapter II was dedicated to showing how the 
presence of methylparaben and cisplatin affect the thermodynamics of micelle formation, and 
resolving where within amphiphilic copolymer micelles various drugs of a certain hydrophilicity 
are situated. Chapter III studied how temperature and the presence of cisplatin affects the 
structural evolution of phase formation in PEO-PPO-PEO solutions. Chapter IV showed how 
temperature and different ternary additives affect the diffusion for controlled release and driving 
force for forming colloidal gels. Finally, Chapter V was a unique study that analyzed how to 
form micelle gels mixed with fire retardants to study flame resistant properties when applied 
onto cotton fabrics.     
In Chapter II, Differential Scanning Calorimetry was performed on a series of aqueous 
solutions of polyethylene oxide-polypropylene oxide-polyethylene oxide, PEO-PPO-PEO, 
(L101, P104, P105, and F108) amphiphiles in the low concentration regime (0-2/% mass v-1) to 
resolve the critical micelle concentrations (cmc) of the neat polymers. We confirmed the cmc for 
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P105 to be ~0.4%w/v at 26.3ºC, which is close to but slightly larger than 0.3%w/v at 25ºC of 
Alexandridis et al. [119, 120]. Increasing Pluronic P105 from 4% to 10% reduced Tmicelle and 
raised the endotherm. Work was done from 2% mass v-1 to 10% mass v-1 (in 2% mass v-1 
increments) amphiphilic copolymer concentrations and co-formulated with cisplatin and 
methylparaben concentrations (0% mass v-1 - 0.1/% mass v-1 in 0.02/% mass v-1 increments) to 
resolve any deviation in the enthalpy of micelle formation. Enthalpy-entropy compensation plots 
for each neat copolymer and each amphiphile solution mixed with drug were obtained. The 
compensation temperature, Tcompensation, was determined from the analyses for neat P105 as 293.9 
K; adding MP raises this to 328.43K. This change was compared to Bouchemal’s Tcompensation of 
293.3K for neat F127 and 316.5K when loaded with 1,2-propanediol [121]. For added cisplatin, 
two types of behaviors were observed; a drug influenced compensation temperature profile 
(P104), and a drug invariant behavior (L101, P105 and F108) where the change in compensation 
temperature was less than 1 K. Only neat P104 was found to be profoundly influenced by the 
presence of cisplatin that must reorganize the core/shell interface between the hydrophobic and 
hydrophilic regions of the micelle. Adding cisplatin lowered Tcompensation from 302.1 to 288.8 K 
for Pluronic P104.  Our findings present a rationale for explaining how the presence of a ternary 
additive, like MP and cisplatin, interacts thermodynamically with forming micelles, and the 
potency of the interaction between drug and micelle might regulate drug bioavailability. 
In Chapter III, the arrangement into cubic lattices of aqueous solutions of PEO-PPO-PEO 
triblock copolymers as their temperature is raised was analyzed. This structural evolution is seen 
macroscopically as a gelation, and the presence of these ordered phases can be controlled 
through both polymer concentration and temperature. The presence of added solutes within the 
dispersions can also affect the onset and kinetics of structure formation. In Chapter III, we 
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investigated the structures formed in the amphiphiles P104, P105, and F108 solutions at 31% 
mass v-1 both neat and co-formulated with the chemotherapeutic drug cisplatin (0.02% to 0.1% 
mass v-1) using small-angle X-ray scattering (SAXS). We observed both the progressive 
evolution and breakdown of these structures as the temperature is increased from 10oC to 35oC. 
The size of the unit cell as well as the thermal expansion coefficients for each system was also 
calculated. As the samples were being heated, added cisplatin changes the nucleation behavior of 
fcc or bcc phases within the sample from a homogeneous process to a more heterogeneous 
distribution of nucleated species. For P104 and P105, added cisplatin enhanced the structural 
ordering with sharper peaks. Unexpectedly for F108, added cisplatin showed the opposite effect 
as the intensity decreased indicating a destabilization of the ordered phases. The presence of 
cisplatin also caused the primary peaks of the F108 structure factor to be suppressed, while 
preserving the higher order peaks. Understanding where chemotherapeutic molecules as ternary 
additives are partitioned within micelles and how they influence the evolving structure is 
important to optimize controlled release systems utilizing amphiphilic copolymers as a drug 
delivery system.  
In Chapter IV, dynamic diffusion experiments were performed on aqueous polymeric 
micelles mixed with the ternary additives: malachite green (0.05% mass v-1), erythrosin (0.1% 
mass v-1), and cisplatin (0.1% mass v-1) to gauge their release from sequestered structures using 
Ultraviolet-Visible spectroscopy. The additives were formulated with 20% mass v-1 aqueous 
solutions of PEO-PPO-PEO (F127). Each additive was tested neat at room temperature, neat at 
40°C, and formulated with F127 at room temperature, and 40oC. After making calibration 
curves, the dynamic release for each ternary additive and corresponding diffusion coefficients 
were calculated.  Results showed F127 retarded permeation at room temperature. In general, the 
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neat additives at 40°C showed the highest permeability for both malachite green and erythrosin.  
Malachite green released almost 90% of the dye by 60 minutes of permeation.  When formulated 
with F127 at 40oC, sizeable release was still noted, but with an induction period of 10-30 minutes 
to register release. The behavior with cisplatin was more complicated as the first 5 hours of 
permeation resulted in a burst delivery with cisplatin (6% total release with cisplatin-F127-RT 
compared to 4% total release cisplatin-RT) but with overall lower release. The higher fluence at 
elevated temperature is attributed to reducing the blocking effect of the amphiphiles on the walls 
of the dialysis tubing as they are directed to form colloidal gels.  There is also likely a correlation 
between higher temperature and higher overall permeability if the membrane pores also expand 
with temperature. Our cisplatin results were compared to a number of other studies in which 
permeation in a sequestered nanostructure was evaluated for its fluence [181, 182]. Adding the 
amphiphile lowered the permeability of dye molecules (2.6 ± 0.01 x 10-7 cm2s-1 MG-RT 
compared to 2.6 ± 0.01 x 10-8 cm2s-1 MG-F127-RT), but tended to result in a burst delivery with 
cisplatin (6% total release with cisplatin-F127-RT compared to 4% total release cisplatin-RT). 
We also noted instability with cisplatin in aqueous solution [168-171].  
In Chapter V, cotton fabrics with flame retardancy were made from gel coatings applied 
from a single bath solution formulated with polymeric micelles and flame retardant amphiphiles. 
The flame retardant coatings were made from aqueous formulations of PEO-PPO-PEO (F127),  
in the low concentration regime (15% w/w), mixed with melamine (5%-15% w/w) and sodium 
hexametaphosphate (SHMP) (5%-15% w/w). After coating, the cotton fabrics were more 
difficult to ignite and, if ignition occurred, the coatings would self-extinguish. Vertical flame 
testing (VFT), micro-scale combustion calorimetry (MCC), thermogravimetric analysis (TGA), 
and scanning electron microscopy (SEM) were used to evaluate the coating quality of the flame 
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retardancy. Coated cotton decomposed at higher temperatures, as shown by MCC and TGA. 
While there is a need to optimize the coating conditions to yield an appropriate thickness 
compared to those reported in Chapter V, the combination of SHMP and melamine packaged in 
an amphiphilic matrix raises cotton flame retardancy. Overall, the scheme for using precursors 
that result in the formation of a solid phase, insoluble flame retardant in a coating seems valid, 
although larger amounts of qualification testing and better tools to provide for a thinner and more 
controlled thickness are appropriate. 
6.2  Future Work 
 The data presented in this dissertation presents a more complete picture of the specific 
interactions of ternary additives and PEO-PPO-PEO micelle structures. In certain situations, 
other additives produced different behavior in the resulting micelle gels. Added hydrophobic 
methylparaben changed the thermodynamics of micelle formation in P105 gels for compensation 
temperature, but added hydrophilic cisplatin showed an invariant behavior where the change in 
compensation temperature was less than 1 K. Only neat P104 was found to be profoundly 
influenced by the presence of cisplatin that must reorganize the core/shell interface between the 
hydrophobic and hydrophilic regions of the micelle. This suggests that differences in the 
molecular interactions between micelles and hydrophilic/hydrophobic ternary additives can lead 
to a different resulting behavior. DSC experiments of solutions containing P104 and 
methylparaben may help interpret how dissolved methylparaben affects the energetics of 
micellization of Pluronic P104. Overall, a more detailed investigation into the specific 
interactions that take place between ternary additives of a certain hydrophobicity is needed to 
offer a molecular explanation for the observed changes. Nuclear magnetic resonance (NMR) 
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may prove useful in determining the types of intermolecular interactions that are being formed 
between molecules of amphiphilic micelles and ternary additives.  
 Although the scattering studies presented here analyze the structural changes in the 
micelle lattice, other techniques are also available. Most notably, Small-Angle Neutron 
Scattering (SANS) as opposed to SAXS may optimize the scattering contrast between the 
micelle core and the micelle shell, which would help better determine if changes in the micelle 
lattice were a result of changing core size, or if the micelle shell was similarly being affected by 
added cisplatin. SANS would be especially useful with added cisplatin because of its high 
neutron scattering capabilities. The platinum, chlorine, and nitrogen atoms each produce high 
neutron scattering data which is shown in Figure 6.1. Similar methods have been carried out 
previously by Sharma et al. [13] using F127 and methylparaben, dibucaine, lidocaine, tetracaine, 
paclitaxel, baccatin III, sulindac, ethyl paraben, and propyl paraben. In addition to SANS, 
Dynamic Light Scattering (DLS) could also be used to see how adding ternary additives affect 
micelle size. Our group previously used DLS to analyze the affect methlyparaben has on the 
micelle size of F127 [16]. 
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Figure 6.1: The variation of neutron scattering lengths as a function of atomic number. 
 
 Efforts to apply these characterization techniques to more hydrophilic or hydrophobic 
additives are also worth further study. Results for more hydrophilic/hydrophobic or high 
molecular weight/low molecular weight additives can be used to generalize observed trends and 
create models for a particular additive and a corresponding amphiphilic micelle. These models 
can be used to help explain the result of a particular ternary additive interacting with a particular 
amphiphilic triblock copolymer. This would allow predictions that are more accurate in the 
micellization and aggregation behavior of amphiphilic copolymers in complex formulations. 
Studying other ternary additives like carboplatin in PBS solution instead of aqueous solutions 
may also help to understand the stability issue as well as the linkage between forming structures 
of amphiphiles housing other molecules and the effect on availability and performance in real 
world applications.    
 To further study the kinetics of gel formation in amphiphilic copolymer solutions, 
Rheology could be used to measure its thermophysical properties at different heating rates. Our 
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group previous used Rheology to study the thermophysical properties of F127 with added 
methylparaben using ramp rates of 0.1-10oC min-1 [16]. An expanded set of Rheology studies 
targeting the kinetics of the gel transition at different heating rates would produce useful 
information on the process of gel formation itself.  
For the fire retardant work in Chapter V, commercialization of this new technology will 
require extensive testing and characterization to ensure the technology complies with 
environmental, health, and safety requirements. This will require a better understanding of how 
the technology deteriorates the routes of exposure and the toxicity of the deterioration products 
and the probability of the deterioration and exposure. Though the risk of exposure at levels that 
can cause harmful effects is quite low, which is why these compounds are still used in a variety 
of commercial products. Additional research is needed to improve the wash durability of these 
coatings and reducing the mass gain and stiffness (hand) of the fabric upon coating. 
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